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Summary
This thesis is largely concerned with the study of a series of compounds, 
related to 15*l6-dihydrocyclopenta-/"a^-phenanthren-17-one, which have 
very specific structure—activity relationships.
Chapter 1 deals with the general tritiation of a number of these
3compounds, where labelling patterns were analysed using H-nmr spectro-* 
scopy. Similar studies were also performed on a related series of poly- 
aromatic hydrocarbons.
The results of the detritiation kinetics,in aqueous sodium hydroxide, of
O
a number of ^ lG- H^-15* l6-dihydrocyclopcnta-^”a_7-phenanthren-17-ones 
similar ketones are presented in.chapter 2. The results allowed inter­
pretation in terms of both inductive effects and the three-dimensional 
shape of the molecules.
Comparative in vitro metabolism of a number of 15?16-dihydrocyclopenta- 
ZTa J -phenanthren-17-ones, reported in chapter 3» showed that all of the 
compounds produce a trans-3,4-dihydrodiol in similar amounts, with the 
exception of the 1-methyl isomer, which yielded a 4-phenol. The mere 
presence of such a diol was shown,not to necessarily imply carcinogenic 
activity in the compound under study.
In chapter 4 the results of an investigation of the binding to DNA in vivo 
and in vitro of a series of 15? l6-dihydrocyclopenta-/£~aJ7“Pbenanthren-17-ones 
are given. Each gave similar adduct patterns, where the major product is that 
derived from a deoxyguanosine residue. The dose/binding ratio of the 
11-methyl derivative shows a linear relationship over a 32-fold range of dose, 
whilst the excision of the adducts from the DNA of the 12-methyl isomer is at 
a rate faster than that of cell division.
The final chapter is concerned with the tritiation of a number of nitro and
amino aromatic compounds, of interest in cancer chemistry. This was done
either by direct catalytic exchange or by introducing the isotope as part of
3
a synthetic step. The H-nmr spectra of the products are presented.
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General Introduction
2Introduction
With the advances in medical science in the last fifty
years and the effective eradication of diptheria, scarlet
fever and poliomyelitis in the Western World, cancer has
become the most feared of diseases. In the advanced countries
1
of the world, it rates among the top three causes of death.
In England and Wales in 1970, 20.4% of deaths were attribut­
able to one form or another of malignant neoplasms, although 
5 0 .6% of deaths were caused by circulatory disease of one 
form or another, mainly arteriosclerotic and degenerative 
heart disease.^
The disease is not, however, merely a phenomenon of modern
Western Society, clinical descriptions of cancers from
between 3000 and 2^00 BC, in ancient Egypt having been 
3
recorded. The ancient Greeks were also aware of the
manifestations of the disease, Atossa, the wife of Darius,
King of Persia, suffering from a massive and ulcerated
cancer of the breast. They also provided an interpretation
of the disease, Hippocrates ( 400 BC) stating that it was
4
due to excess black bile I Additionally the incidence of
cancer in the Third World and non-developed countries is
high in places. For example aesophagealcancer is prevalent
5
xn parts of Iran, as is cancer of the penis in Uganda.
Despite the extensive research performed over the last 
hundred years, a great deal still needs to be learnt
3concerning cancer. As with the infectious diseases, a 
true understanding will ultimately only come from an 
appreciation of the cellular nature of the disease. As 
yet no absolute definition can be given.
A cancer cell develops from a normal cell, by a method or 
methods as yet not fully characterised. As this cell 
divides, it reproduces a second cancer cell, which in turn 
divides again. Unlike the infectious diseases, which cause 
death to the cells the bacteria inhabit, the cancerous 
cells do not cause death, or destroy other cells. A cancer 
cell will grow and replicate with much less restraint than 
the strict regulation that typifies a normal cell. Addition­
ally the transformed cells do not perform the usual functions 
in the body, including that of dying. As these cells invade 
the normal tissue, death occurs by a variety of means. The 
major cause of death, accounting for k7% of cancer deaths 
is that of bacterial infection, whilst 2 5% of cancer deaths 
occur by direct interference of the mass of cells with a 
vital organ, typically lungs, liver, brain, or kidney.
Other deaths are from emaciation (10%) and haemorrhage (7%i 
frequent in leukemia sufferers). Prior to death, secondary 
cancers have usually formed by the process of metastasis.
(The spreading of cancer cells throughout the body.)
The cause of the original change within a normal cell, to 
produce a malignant species, is thought to be induced by one 
of three methods. Oncogenic viruses have been implicated
7 8 9 10in both human and animal cancers. ’ ’ 1 Radiation
11 12induced cancers are well documented, 1 though only a 
small proportion of cancers are thought to have this as 
the cause. Such radiation includes ultraviolet, X-ray
13and the effects of radioactive elements such as radium.
The fallout from nuclear bombs in war and in tests has also
produced grim evidence of the effect of radioactive
. i 14, 15substances.
The major cause of cancer is thought to be the action of 
chemical compounds of one form or another. This includes 
both natural and man-made materials. Various reports quote 
different figures for the proportion of human cancers 
caused by enviromental and chemical agents, ranging from 
75-90% . ^ 1 ^ 1 ^  Such estimates, of course, are
extremely difficult to verify.
Sir Percival Pott, a London surgeon, was the first to
implicate chemical agents in carcinogenesis, in 1 7 7 5 1 when
he noted the high incidence of scrotal cancer in chimney
sweeps, which he suggested was caused by some agent present 
20in soot. It was not until over a century later that skin
tumours were experimentally induced in animals, using
coal tar extracts $ this was achieved by the work of Yamagiwa 
21and Ichikawa.
Since then, a great deal of work has been performed in 
isolating and identifying the active components of such
5mixtures. Many different types of chemical carcinogens 
have now been identified, and their tumourogenic properties 
determined, indicating certain unifying features in their 
biological action. All appear to be, or are metabolised 
into?electrophilic reagents, where the significant target 
appears to be DNA.
Known carcinogens may be categorised by their structure
into different types. The first group to be discovered were
the polyaromatic hydrocarbons. They are widely distributed
in the environment, largely due to inefficient combustion
22 23of fossil fue^s. ’ Of these compounds benzo/-a__7pyrene
24
( I )  has been the most widely studied, being an active
25constituent of soot. Many synthetic compounds have been
synthesised, and tested in animal experiments with a wide 
range of activities reported. Those that are biologically 
active include 7?12-dimethylbenz/ a_7 anthracene (II),
97
3-methylcholanthrene (III), and dibenz/~a,h_7anthracene 
28
( IV ). Many of these aromatic compounds possess a phenanthrene
nucleus, and substitution within the so called Mbay-regionM
often causes greatly enhanced tumourogenicity. For example
the carcinogenic activity of 5-methylchrysene (V) is far
29greater than the parent compound. J Similarly the extreme
potency of benzo / a._7 pyrene (I) is increased by the
30substitution of a methyl group at position 1 1.
/
6Bay
Region
9
8
Bay
Region Bay1 Region
Epidemiological studies of workers in the dyestuffs industry
led to the identification of p-naphthy1amine (VI) and
31 32 33benzidine (VII) as carcinogens. ’ 1 Additional
studies revealed that other aromatic amines were implicated 
in carcinogenesis. These compounds have a tendency to 
induce tumours in the bladders and urinary tracts of affected 
species. Structurally related carcinogenic compounds, 
which are of particular interest include 2-acetamidofluorene 
(A.A.F., VIII) and the so called "Butter Yellow" (IX). The
3(tformer was originally synthesised for use as an insecticide,
whilst the latter was used as a food colourant until it was
35banned in 1 9 3 3-
7COCH.
Nitrosamines, e.g. dimethylnitrosamine (X), have been 
found in cured food products^’ ^  when b'acon is
o o
fried.^ It is also quite likely that the ingestion of 
nitrates can lead to the spontaneous formation of nitrosamines. 
These compounds are also widely used in synthetic organic 
chemistry.
c h 3
N N = 0  X
ch/
\
Another general group of carcinogens are often denoted as 
the "Alkylating Agents", which is not a strictly accurate 
description, as some require further activation prior to 
DNA attack. Compounds so grouped include mustard gas (XI) , 
nitrogen mustard (XII) , (3-propiolactone (XIII) , and \d.nyl
39-4chloride (XIV), all of which have been shown to be carcinogenic. 
Indeed the four general groupings do not adequately describe
44all known tumourogenic compounds, such as ethionine (XV)
Zj.5
and 4-nitroquinoline oxide (XVI).
/
S
\
CH2CH2CI
c h 2 c h 2ci
XI
CH3 - N
^ c h 2 c h 2ci
\ C^GHgCI
XII
XIII
XIV
ICl
NH/
XV
Carcinogens are not merely products of a modern industrial­
ized society, as naturally occuring carcinogens are known. 
Studies have been performed on aflatoxin B1 (XVII), a 
metabolite of Aspergillus flavus, commonly present in food 
as a spoilage fungus. The deaths of a hundred thousand 
ducks and turkeys on British farms in 1960-1, initiated 
research on the mould, when the source of the aflatoxins was
46traced to a shipment of Brazilian peanut meal. The 
carcinogenicity of the compounds was' later confirmed in 
animal experiments.^
9XVII
OCH
Extensive studies have been performed on the 15»l6-dihydro-
cyclopenta-/~a7-phenanthrene (XVEI) series of compounds,
which are related to both the polycyclic aromatic hydrocarbons
and the steroids. Although the 7- and 11-methyl derivatives
exhibited weak carcinogenic activity, the parent compound 
47was inactive. Marrian et al demonstrated the presence of
18-hydroxyestrone (XIX) in the urine of pregnant women.
This could easily lose the hydroxymethyl and with subsequent 
dehyd r o genation yield 15?l6-dihydro-3-hydroxycyclopenta- 
/ a__7-phenanthren-17-one (XX). He proposed that this could 
be a carcinogen, being related to the known carcinogen
483-methylcholanthrene (III). However, on testing, this
49compound proved to be inactive, but the synthesis and 
biological testing of a series of compounds related to this, 
demonstrated that some did indeed possess tumourogenic 
properties, with very specific structure-activity relationships.
10
OH
CH.
XIX
HO
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4 6
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HO
15 j l6-Dihydrocyclopenta-/ a__7-phenanthren-17-one (XXIa)
50is inactive, as are the 2-,3-»^-i6- and 12-methyl
derivatives (XXI c,d,e,f ,i)„^  The 1-methyl compound
(XXIb) is currently being tested on mice, but is thought to
be inactive. The 7- and 11-methyl isomers (XXIg and h),
52 53are active in animal tests, 1 with the latter being the
  52
most active, similar in potency to benzo-/ a_/-pyrene.
Other compounds in the series which show carcinogenicity
include the ll-.hydroxy (XXIj),^ 11-methoxy (XXIk),^
11-ethyl (XXII),^ 1 1,12-dimethyl (XXIm),^° 7,11-dimethyl
(XXIn)^ and the 1 ,11-methano (XXIl)^ ketones.
11
R*
a ,1 -H
b, 1 -Me
c, 2 -Me
d, 3-Me
e, 4 -Me
f , 6 -Me
g , 7-Me
h , 11-Me 
i , 12-Me 
j , 11-OH 
k , 1 1 -OMe 
I , 1 1 - Et
m, 11,12-Dime 
n , 7,11-Dime
X-ray studies and molecular orbital calculations have 
shown that carcinogenic properties in these compounds
56 57were associated with strain within the aromatic nucleus. 1
Extensive biological investigation of the 11-methyl ketone
(XXIh) both inwivo and in vitro has established that of the
metabolites formed, the trans-3»4-dihydrodiol (XXIII^is the
58 59 60proximate carcinogen. ’ The major DNA-adduct in
both conditions is derived from an anti-3 14-trans-dihydrodiol-
1,2-epoxide (XXIV ) , ^ ’ which then undergoes attack on
the exocyclic amino group of a guanine residue in the DNA
(XXV). This adduct is not actively removed by enzymes
from mouse skin or lung,^’ and adducts were still
58detectable in skin thirty days after application. The
12-methyl compound (XXIi) is metabolically activated in an
6kexactly analogous manner, yet with apparently none of 
the tumourogenic properties. Comparative studies of
XXI
64
o
XXII
12
metabolism, DNA adduct formation and adduct repair ■will 
help to elucidate the reasons for inactivity in this 
particular isomer.
Much of the work performed over the last few decades in 
the life sciences has been heavily dependent upon the use 
of compounds labelled with radioisotopes. The ease with 
which very small quantities of labelled material may be 
detected has promoted their extensive use.
The additional benefits of being able to rapidly locate 
the desired extraneous chemical in a biological system, 
provides further support for their use. Whilst phosphorus- 
3 2 , sulphur-35 and iodine-125 have found wide use in such 
research, carbon-l4 and tritium (hydrogen-3) have been 
utilized to an even greater extent. With relatively long 
half lives (5 5 7 0 and 12.3 years respectively) fcnd being
weak p'emitters, they are ideally suited to safe usage in 
research. Although carbon-l4 may be detected using a 
Geiger-Muller tube, the energy of the ^"-particle associated 
with tritium emission is too low, and so detection is 
achieved by liquid scintillation counting.
The incorporation of either of these radioisotopes into 
chemicals may be achieved by many means. C a r b o n - m a y  
only be introduced as part of a synthesis (either classically 
or biochemically)• Such procedures are often lengthy and 
lead to a small proportion of the original label in the 
final product. The methods available for the introduction of 
tritium include similar synthetic means, but methods for 
introducing the radioactivity into the final product, or 
immediate precursor, are also available.
There are three main sources of tritium, namely the gas, 
tritiated water, and tritiated metal hydrides. The ase of these
65materials has been extensively reviewed by Evans. The
gas may be used to add across double bonds, e.g. the 
tritiation of 3o<~ hydroxy-17-oxo-an dr os t-5-ene (XXVI) to
o cc
3<*-hydroxy-17-oxo-5d/~5,6- H_7-androstane (XXVII)* It
may also be used in catalytic dehalogenation reactions such
as the transformation of meta-bromochlorobenzene (XXVIII) to
/""3-3h_7- chlorobenzene (XXIX).^
Ik
XXVI
HO'
XXVII
HO
XXVIII
Exchange reactions may be utilized for introducing the
isotope into specific positions. Labile sites may be
labelled simply by the use of tritiated water, e.g. the
68labelling of malonic acid (XXX) , where tritium is found 
attached to a carbon atom as well as in the acid groups (XXXI) 
By using a catalyst, tritium may be introduced into non- 
labile positions. Such catalysts include simple mineral 
acids, e.g. the tritiation of L-5-hydroxytryptophan (XXXII) 
at 100°C for several hours, leading to exchange into both
the benzene and indole rings. 69 Simple bases, such as
sodium hydroxide, have been used to methyl label acetophenones
70 71(XXXIII) and similar compounds. 1
CH2 (C 00H ) 2  c h (c o o t ) 2
' T
XXXI
XXX CH3X
NH
H
XXXIII
XXXII
15
The use of* heterogenous catalysts enables the isotope to 
be incorporated into sites that do not usually exchange. 
Such methods have been ■widely used, especially in the
labelling of* aromatic compounds, e.g. the preparation of*
Other catalytic 
65, 74, 75, 76
72 73tritiated polycyclic compounds. ’ ytic
methods have been extensively reviewed.
In any tritiation, doubt will exist as to the position of* 
the label. Chemical degradation experiments are not only 
extremely time consuming, but open to many inaccuracies.
The development of* tritium nuclear magnetic resonance has 
enabled accurate determinations of* the labelling patterns 
in labelled compounds. With a spin quantum number of*
I=-J, and possessing an n.m.r. frequency of 106.66 MHz at 
23-5 Tesla, tritium is the most sensitive nucleus for 
detection by n.m.r. A recent review summarized the practical
77aspects of such work. Because of the virtual identical
1 2  3chemical shifts of the H, H and H nuclei under the same
•j Q  7  Q
conditions, ’ direct comparisons may be made. Under 
usual circumstances, the isotope concentration is not high
q  o
enough to produce / H- H 7  coupling. By proton decoupling, 
a simplified spectra results, where each triton is represented 
by a single line. Proton coupled spectra are often useful 
in assigning the triton spectra.
This technique has been widely used to study the distribution 
of tritium in compounds as diverse as amino a c i d s , ^  
carbohydrates,^’ ^  aromatic polycyclic hydrocarbons, ^ 1 ^
i  ^ i 4- • ^ ^  1 8 6 , 87nucleosides and nucleotides, steroids,
88 89heterocyclics, and neurochemicals. Other compounds to
90have been studied include drugs, such as Vinblastine
91 3sulphate (XXXIV), -where H-n.m.r. was the only reasonable
possibility for determining the position of the label, due
to its complex nature, and susceptibility to vigorous
reaction conditions.
o h
c h .
3
As H-n.m.r. has become more sensitive (O.fjmCi in a single 
site is detectable), so it has started to be used in bio­
chemical studies. Compounds studied include penicillic
acid (XXXV) , 921 93 cycloortenol (XXXVI)9^ and isobutyrylCoA 
95(XXXVII). The technique has also proved useful in the
understanding of reaction mechanisms including hydrogenation 
96 84 7reactions, rearrangements and proton transfer problems.
3
Use has also been made of H-n.m.r. in the analysing of
mixtures by tritiating specific sites, e.g. in shale oil 
97mixtures.
17
COSCoA
— C«3
XXXVI/
CHi>\
CH,
XXXV
XXXVI
HO
OH
The availability of tritium-n.m.r• together -with techniques
98 99such as radio-gasiiquid chromatography, 1 radiothin-
layer chromatography and high performance liquid chromato­
graphy (H.P.L.C.) enable tritiated compounds to be used 
with increasing confidence for both chemical and biological 
research.
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1.1 Introduction
Over the last 10-15 years tritium nuclear magnetic resonance 
3
spectroscopy (H-nmr) has become established as the best 
non-destructive, accurate and relatively rapid, method 
for measuring the distribution of tritium in tritiated organic 
compounds. Most of the important categories of organic
compounds, such as steroids,^ ^  amino a c i d s , 1 ^
Zj. 7 g
carbohydrates ’ and carcinogenic hydrocarbons have been
analysed by this technique.
It follows that as a result of this development, the attractions 
of using tritiated organic compounds is greatly increased, 
and some of the more important applications of this method 
have been in the area of catalysis. For example, the 
investigation of selectivity of catalysts, the mechanisms 
of certain reactions such as hydrogenations, and the value 
of using homogeneous or heterogenous catalysts.
3
Some years ago, the preparation, and H-nmr spectrum of
15»16- dihydro, 11-cdethylcyclopenta /""a_7 phenanthren-17-
/ \ 9one (lb) was reported. The work discussed in the present
3
chapter deals with the preparation and H-nmr analysis of 
some compounds of this type (Ia-Il), as well as a number 
of structurally related polycyclic aromatic compounds (III- 
VII). This has been done in the belief that the tritium 
distribution data and analysis will be of considerable use 
to those concerned with using such compounds in biological
32
studies, as well as providing the labelled compounds 
required for metabolism and DNA binding studies. (Chapters 
4b and ) Some of these compounds are very insoluble in 
organic solvents, and so investigation has been made as 
regards the suitability of 10mm rather than 3mm nmr tubes. 
The way in which this affects detection limits will be 
discussed.
10
16 b, 1 1- Me 
c, 12-Me 
1 5  d* 11,12-Dime 
e, 6 - Me
1 10IV
16
15
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In many laboratories deuterium, being non-radioactive,
is preferred to iritium. Deuterium is not a very good
nucleus (in terms of sensitivity) for nmr purposes (e.g.
spin = l). Nevertheless, with the development of Fourier
Transform instruments capable of operation at high frequencies, 
2
H-nmr of enriched samples has become a viable proposition.
2For this reason, some -'H_7-labelled compounds have
been prepared, so that a comparison of the relative attractions 
2 3
of H and H-nmr spectroscopy can be performed.
1,2 Experimental
1.2.1 Materials
All the 15, l6-dihydrocyclopenta / a__/ phenanthren-17- 
ones were obtained in a pure state from the Imperial Cancer 
Research Fund Chemistry Laboratory. The other compounds 
were either available or purchased commercially, and were 
purified prior to use. The catalysts were also obtained
_ i
from commercial sources and the tritiated water (50Giml ) 
supplied by Amersham International P.L.C.
1.2.2 Methods
1.2.2.1 Preparation of Freshly Reduced Platinum Dioxide
Platinum dioxide (70mg) was taken in distilled water (70ml) 
and sodium borohydride (300mg) added slowly. The mixture was 
heated to 70°C, to complete the reduction. The catalyst was 
washed with water, which was then removed. Glacial acetic 
acid was normally used to further wash the catalyst, in 
order to prevent isotope dilution. The catalyst was used 
immediately.
1.2.2.2 Preparation of Raney-Nickel Catalyst
Raney-nickel (400mg) was gradually added to sodium hydroxide 
(10%, 6ml), whilst maintaining a temperature of 9 0-9 5°C.
35
This was stirred for one hour by non-magnetic means. The 
solution was carefully removed and the catalyst used 
immediately.
1.2.2.3 Typical Catalytic Tritiation Procedure
The appropriate quantity of freshly prepared catalyst was 
transferred to a hard glass reaction tube. To this was 
added the substrate, either as a solid or a solution in 
glacial acetic acid. Tritiated water (50Ciml ) was also 
added as required. The tube was then evacuated, sealed and 
placed in an oil bath at the necessary temperature for the 
desired length of time.
On completion of the reaction, the contents of the tube were 
poured into water. From this the product was extracted 
using n-pentane or chloroform. The organic solutions were 
then dried using anhydrous sodium sulphate, filtered and 
the solvent removed by freeze drying. Samples were dissolved 
in a deuterated solvent (benzene, chloroform or dimethyl 
sulphoxide), the radioactivity determined, and if sufficient
Q
(i.e. >2mCi) sent for H-nmr analysis. A summary is given 
in table 1.1.
Table 1 . 1 -  Details of the PtQ^, tritiations of the 
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1.2 .2 .4 Tritiation and Purification of 15,l6-Pihydro- 
cyclopenta-/ a 7-phenanthren~17-ones
Those compounds not tritiated at the University of Surrey 
(la-11) were labelled at Amersham International P.L.C. 
(Cardiff), using the following conditins. The ketone (lOOmg) 
was taken up, together with pre-reduced platinum catalyst
o
in 70%-/ H_7acetic acid, where 1ml contains 400 Curies.
This was heated at 150°C for l6 hours in an evacuated, 
sealed tube. Readily labile tritium was removed by equili­
bration with ethanol. The compounds were supplied as 
solutions in ethanol and further purified by column 
chromatography. Because of the high specific activities of 
these compounds (in the range 1-llCimmol"’ ) it was, for 
reasons of safety, inappropriate to use thin layer chroma­
tography techniques. This could also have led to an 
acceleration in the rate of self-decomposition.
The compounds were dissolved in dichloromethane, and eluted 
from a silica gel column with the same solvent. Fractions 
were collected and samples spotted on t.l.c. plates to 
determine the chemical purity. Radio-t.l.c. scanning, was 
used to check the radiochemical purity of such samples.
Those containing the pure compound were combined, and the 
solvent removed. Samples were kept in the solid state for 
the minimum amount of time, and after removal of dichloro­
methane, were dissolved in dry benzene (100 ml) and stored 
at 0-5°C prior to use. The chemical concentration was
determined by removing a known quantity from these solutions, 
evaporating the benzene, dissolving in a known quantity 
of methanol, and a U.V. spectrum of this solution obtained. 
This was compared to a standard curve (intensity v. concen­
tration ) for that particular compound (e.g. fig. 1.2.2.4i).
3
For H-nmr analysis the compounds were dissolved in 
d/--benzene or deuterated chloroform.
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F i g .  1 . 2 . 2 . 4 i  Standard Curve for the 11-methyl ketone (lb)
Removal of* the labile tritium at position l6 of the
labelled ketones was performed by heating a solution of
the tritiated compound under reflux with an acetic acid
and concentrated hydrochloric acid mixture (270ml; kil v/v).
Of this, 250ml was distilled off and the process repeated
three times. The final solution was then diluted with
the extract
water, extracted with dichloromethane and^chromatographed
on silica gel t.l.c. plates (toluene, ethyl acetate,
methanol, 15:5:1)- The product was removed from the plate,
3
and a H-nmr spectrum obtained in deuterated chloroform.
This allowed an unambiguous assignment of the signal for 
tritium at the C-l6 position. Such spectra are denoted 
*Aryl'.
1.2.2.5 Catalytic Deuteration Method
Deuterations were performed in an analogous manner to that 
of the tritiations using reduced platinum pxide catalyst. 
However the isotope source was almost 100% deuterium oxide 
(D^O). When a solvent was required, to prevent any dilution 
of the deuterium pool, deuterated acetic acid (CD^CO^)
j "
was employed. The compounds, together with the solvent 
and catalyst, were sealed in hard glass tubes, and heated 
at 170°C for a week. The details are given in Table 1.2
kl
Table 12 Details of the PtO^ catalysed deuterations of 
polyaromatic hydrocarbons
Compound Mass
(mg)
10Pyrene (VII)
Benzo- /“aJ -  
pyrene (VIII) 10
Catalyst Volume
(mg) of D20(|il)
50
50
100
100
Volume of 
Solvent (ill)
500
Table 1.2
VIII
The products were isolated as for the tritiated compounds,
dissolved in ordinary dimethyl sulphoxide (60^ il) , sealed
2
in 3mm nmr tubes and sent for H-nmr analysis to the 
University of Warwick S.E.R.C. nmr service.
1.2.3 N»M.R. Tubes used for H-nmr
Usually samples were sealed in 3mm nmr tubes. However in 
some cases, because of solubility problems, it was necessary 
to employ a larger volume of solvent, in which case a 10mm 
tube was used, fig. 1.2.2.6.
k2
"H r 
3mm
I*— I
10 mm
F ig .  1 . 2 . 2 . 6  Nftir tubes
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1.3 Results and Discussion
1.3*1 Platinum Oxide Catalysed Tritiation of Polyaromatic 
Hydrocarbons
The results are summarised in Table 1.3 and in Figures 
1.3*li-v * In the case of naphthalene (III, Table l.l), 
very good tritium incorporation was achieved after the sample 
was heated for a week and after an increase in the amount
t
3 1of catalyst used. The H-nmr ( H-decoupled) was assigned
1 10 by comparison with the H-nmr spectrum, and as a result
of an experiment on the catalytic tritium-debromination of
1-bromonaphthalene (6=7 .8 9 , CDCl^). Under the conditions
used to achieve the general labelling, equilibrium had clearly
been reached, and this seems to be the case for anthracene
(IV) too, where the 10% difference is probably no higher
3
than the experimental uncertainty. Assignment of the H-nmr
1
spectrum was made by comparison with the standard H-nmr 
spectrum.^
Because phenanthrene (V) is a non-linear molecule, it might
be expected that steric hindrance factors could be important
in the catalytic procedure. Under these experimental
conditions, this is not so. Phenanthrene has a plane of
3 1symmetry and the five signals in the H-nmr ( H-decoupled - 
fig. 1.3«liii)i are approximately the same intensity, with 
but a marginal preference for the 3 and 6 positions. In 
many reactions positions 9 and 10 in the ’E-region' are
the most reactive, -with the ability to effectivly act as 
an independent double band in addition and oxidation 
reactions.
Triphenylene (VI) possesses three planes of symmetry. As 
3 1a result the H-nmr ( H-decoupled) spectrum is relatively 
simple (fig. 1.3»liv). There are only two signals, of
similar, but not identical intensity, suggesting a slight
favouring of the 1,4,5?8,9 and 12 positions.
Pyrene (VII) was tritiated in the absence of acetic acid
at a temperature above its melting point (156°C) and a 
good incorporation was achieved. This procedure may be 
utilized to good advantage where the substrate melting point 
is not too high. The presence of a solvent with an 
exchangeable hydrogen (in the carboxyl group) must be a 
factor in reducing the specific activities. The distribution 
of the label would suggest that equilibrium had not been 
reached, as the quantity found at positions 2 and 7 is 
higher than expected.
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Table 1.3 H-nmr details for the PtQ^ catalysed tritiations 
of polyaromatic hydrocarbons
Compound Nmr
Solvi
Naphthalene CDC1
CDC1
H Chemical Assignments Relative H
Anthracene
S «
Phenanthrene CDC1
Triphenylene CDC1
3
Pyrene
Shifts (ppm) In'
7 . 8 6 l,4,5 ,810 49
7.49 2,3,6,7 51
8.46 9 ,1 010 18
8 . 0 3 1,4,5,8 44
7.49 2,3,6,7 38
8 . 7 2 4,5U 19
7.93 1 , 8 18
7.77 9,10 19
7.69 3,6 23
7.63 2,7 21
8 . 6 7 1,4,5,8 , 
9 ,1 2 10
59
7 . 6 8 2 ,3,6 ,7, 
1 0 , 1 1
4l
8.37 l,3 ,6 ,8 12 35
8 . 2 6 4,5,9,10 36
8 . 1 5 2,7 29
^6
■(>
1 0 8
0 6
hi
i------ 1------1------ 1------1------ 1------1 i I I
9 8 7 6 5 A 3 2 1 0  £
3
F i g .  1 . 3 . 1 1 - v  H-nmr spectra of polyarpmatic hydrocarbons
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1.3.2 Platinum Oxide catalysed deuteration of Pyrene and 
Benzo- £ s J L  -pyrene
The concentration of deuterium in the D_0 (>99 atom %) is
_ 1
much higher than the tritium concentration in 50Ciml HTO
(^2%). Consequently the % incorporation of the label is
much higher, and as the time used for heating the samples
(l week) is relatively long, one would have expected equilibrium
to have been reached. This is indeed the case, at least
for pyrene. A summary of the results is given in Table
1.4 and Figures 1.3«2i-iii.
2
Table 1.4 H-nmr details for the PtO^ catalysed deuterations
Compound
Pyrene »
Benzo- r * j  -pyrene
H-Chemical 
Shifts (ppm)
8.25
8.14 
8 . 0 3
9 . 2 6
9.15 
8.71
8 . 6 3
8.46
8.33
8 . 1 8
8 . 0 8
8 . 0 3
7.87
7.82
Assignments
1,3,6,8 
4,5,9,10 
2,7 
1 0 , 1 1
1 2 ,7 , 1
3
5,2,4
9
8
Relative H 
Incorporation^)
40 
40 
20 
3-7 
11.3
5.0 
6.8 
4.9
14.8 
7-9 
12.7 
V 14.2
9.1 
9-6
^9
2In the case of pyrene, the H-nmr spectrum (Fig. 1.3«2i),
3
like the H-nmr spectra (Fig. 1.3.1v), is relatively simple, 
consisting of three lines. However, they are, as expected,
3
much broader than the sharp H signals and it is to be
expected therefore, that in more complex spectra there could
well be overlapping signals and consequent difficulties in
2
assignment. ' This prediction is well borne out in the H-nmr 
spectrum of /""G- H^JT-benzo-^/^a^y-pyrene (Fig. 1.3.2ii), 
which may be compared with the corresponding ^H-nmr spectrum 
(Fig. 1.3«2iv). Even with a scale-expanded spectrum
(Fig. 1.3»2iii), the signals are not easily separated. This
useful comparison illustrates very nicely a case where
3 2H-nmr spectroscopy has clear advantages over H-nmr
spectroscopy.
ib------- o----:---- f--------£--------«*■
2..Fig.1.3.2i H-nmr of pyrene
50
■& X x ta 7
100 Tsf 709 0 7-58-5 80
Rg1.3.2iv
2 3H & H-nmr of benzo [a] pyrene
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1.3»3 Comparison of the performance of 3mm and 10mm nmr Tubes
11 Millicuries of /_ G-*^ H__/- triphenylene were dissolved in
deuterochloroform (50jj1) and the H-nmr spectrum, obtained
after 36620 scans, is shown in Fig. 1.3-3i- Subsequently
the solution was withdrawn, made up to 1ml with the same
3solvent, inserted in a 10mm tube, and another H-nmr spectrum 
obtained after approximately the same accumulation time 
(35660 scans) - Fig. 1.3-3ii» A comparison of the two 
spectra shows very clearly the higher sensitivity of the 3mm 
tube. The slight difference in chemical shift may be 
attributed to concentration effects (Table 1.5)«
Table 1.5 Chemical Shifts for / G-^H /-Triphenylene in 
different nmr tubes
Tube Chemical Shifts (ppm)
1,4,5,8,9,12 2,3,6,7,10,11
3mm 7 . 6 8 8 . 6 7
10mm 7.71 8.71
I- - - - - - - 1- - - - - - - 1- - - - - - - 1- - - - - - - - 1- - - - - - - 1- - - - - - - 1- - - - - - - - 1- - - - - - - - 1 1 '“ I
10 9 8 7 6 5 4 3 2 1  0  6
These results show that the use of the 10mm tube for
sparingly soluble compounds does not facilitate the ease of 
3
obtaining H-nmr spectra. The alternative is to prepare the
compound at still higher specific activity. This would probably
- 1entail the use of tritiated water of 200 Ciml or higher.
Certainly, in the case of chrysene (IX), which is very
insoluble, a sample containing at least 70mCi would be
3
necessary before a satisfactory H-nmr spectrum could be 
obtained using the larger tubes.
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1.3»4 Raney-Nickel Catalysed Tritiation of Polyaromatic 
Hydrocarbons
Although this catalyst has been widely, and successfully
used to induce many hydrogen-isotope exchange reactions,
in the case of the polyaromatic hydrocarbons studied here
(III-VI), its behaviour was unusual and unexpected. The 
3 1H-nmr ( H-decoupled) spectra are given in Figures 1.3«4i-iv, 
and the essential features are summarised in Table 1.6
3
Table 1.6 H-nmr Chemical Shifts of the products obtained 
from Raney-Nickel catalysed tritiations
3
Starting Material Radioactivity of H-Chemical - m  CDCl
Product(s) (mCi) Shifts (ppm) (% abundance)
Naphthalene (ill) 1.8 1.80, 2.77
Anthracene ( IV) 6.1 1.74(34.7), 1.84(8.7),
2.67(55-3), 2.94(1.3)
Phenanthrene (V) 7-5 1.72(17.9), 1.80(16.2),
2.54(17.9), 2.71(31.5),
2 .88(11.0 ), 3 . 11(5 .5)
Triphenylene (VI) 5.0 1.76(25.4), 2.56(42.2),
2.70(13.4), 3.14(19.0)
5*i
3 2 0
F i g . 1 .  3 . 4 i- iv  ^  nmr of products from raney nickel reduction
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The observed chemical shifts are typical not of an aromatic 
compound, but of a saturated hydrocarbon. In other words 
the catalyst is reducing the substrate, rather than 
catalysing an exchange process. No attempt was made to 
determine the number of products formed. With the benefit 
of hindsight it might have been possible to carry out some 
radio-thin layer or radio-gas chromatographic studies. As 
it is, the H-nmr spectra of the product(s) proved to be 
particularly informative and for this reason, the results, 
summarised in Table 1.7 will be individually discussed
1
Table 1.7 H-nmr details of the product(s) of Raney-Nickel
Probable
Assignment
2,3(1.79) 10
1,4(2.75)
5 ,6 ,7 ,8 (7 . 0 2
2 , 3 ,6 , 7 
1,4
9 . 1 0
2.3
1.4
5.6.7.8.9.10 
2,3,8,9
4,7
1.10 
5,6
catalysed tritiations of polyaromatic hydrocarbons
Starting
Material
Naphthalene 
(ill)
Spectra
Number
1 .3 .4v
Anthracene Fig.
(IV) 1.3-4vi
18 to
Phenanthrene Fig
1 .3 •4vii
Probable Product(s)
1.2.3.4-Tetrahydro- 
naphthalene (IX )
1,2 ,3,4 ,5 ,6 ,7 ,8- 
0c tahydroanthraeene 
(X)
1.2.3.4-Tetrahydro- 
anthracene (XI)
1,2,3,4,7,8,9,10-
0ctahydrophenan— 
threne (XII)
H-nmr 
Signals 
6 (ppm)
1.76
2 . 7 6  
7 . 0 6  
1.75 . 
2 . 7 0  
6 . 7 8  
2.09 
2.95
7.0-7.9
1.74-1.8
2.54
2.73
6.84
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1,2 ,3i4-Tetrahydro- 1.77 
phenanthrene (XIII) 2.86
3.10 
7.00- 
8.00
Triphenylene Fig. 1,2,3,k,5,6 ,7,8 ,9, 1.79
(Vi) 1.3- Wiii 10, 11, 12-Dodecahyd- 2 . 5 6
rotriphenylene (XIV)
1,2,3,4-Tetrahydro 1.79 
(XV) and 3 .11
1 ,2 ,3 ,4,5 ,6 ,7 ,8- 7 .1-8 . 6
Octahydrotripheny- 
lene (XVI)
2,3
4
1
5,6,7 ,8,9 , 1
2 ,3 ,6 ,7 ,1 0, 
11(1.79)10 
1,4,5 ,8 ,9, 
1 2(2 .5 9 )
i.
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F ig s  . 1 . 3 .4v - v i i i  H-nmr of products from raney nickel reduction
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\
In the H-nmr spectra, those peaks at 1.28 and 0.91S 
may be assigned, in part, to n-pentane, and that at 7 .2 5$ 
to chloroform.
In the case of naphthalene (III), the H-nmr results (Fig.
1.3«^v and Table 1.7) seem to indicate that the major product
is 1,2,3 * tetrahydronaphthalene ( ix)• The chemical shifts 
3
from the H-nmr correspond well with the proposed structure.
A slightly uneven distribution of label between the two 
sites occurs•
Anthracene (IV) , has apparently reacted in a similar manner,
the two major products being the octahydro-(X) and
tetrahydro-( X$ compounds, with the central fB f ring
1remaining intact. The integration on the H-nmr spectrum
(Fig. 1.3-^tvi) appears to confirm this, although, some
unidentified signals are present downfield of the n-.pentane.
3
The H-nmr signals coincide with the relevant lines in the 
Si-nmr spectrum.
The retention of the central ring is a feature of the
reaction with phenanthrene (V), where the products were
identified as the octahydro-(XII) and the tetrahydro-(XIII)
derivatives. As with anthracene, the integration of
1
the H-nmr spectra reveals some unidentified products, though 
3
the H-nmr may again be seen to correspond closely with 
the relevant peaks in it•
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Triphenylene (Vi) , provides the greatest number of possible
un
products if the central ring remains ^ saturated. Whilst
the H-nmr spectrum (Fig. 1.3»^viii) remains difficult to
assign, due to the broadness of the aliphatic signal, the 
3
H-nmr spectrum suggests the multiplicity of products.
The aromatic peak at 8 . 6 5 in the H-nmr spectrum, would be 
consistent with a species containing a phenanthrene nucleus, 
which could be the tetrahydro- compound ( X V )• It is 
unlikely that the tetrahydro and dodecahydro-(X IV  ) compounds 
would be present without the octahydro compound (X V I  ) •
IX
XII * • XIII
XI
r XIV
T
XV
XVI
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Whilst Raney-nickel is widely used as a hydrogenation 
catalyst, it has not been previously reported as active 
under these conditions. Neither have direct hydrogenation 
methods to yield these products been reported.
The use of Raney-nickel in ethanol as a reduction catalyst
13for certain olefinic bonds is known, although even under 
reflux conditions benzene rings, aliphatic acids and 
esters remained unreduced.
Polyaromatic compounds are more easily reduced than single
ring compounds• Phenanthrene and anthracene readily undergo
14
reduction of the * B* ring with sodium-ftiercury amalgam 
to yield the 9 110-dihydroderivatives (Fig. 1.3«^ix). 
Similarly naphthalene is readily reduced to the tetrahydro- 
compound (tetralin) by the use of sodium in boiling isoamyl 
alchohol. (Fig. 1.3»^x.)
Fig. 1.3*^ix
IX
Fig . 1.3-^x
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The retention of the *Ef ring in these compounds is without 
precedent in the literature. The absence of any fully 
reduced compounds would imply thenecessity of the remaining 
benzene ring to stabilise reaction intermediates.
It is possible to speculate that under the conditions used
for these experiments, hydrogen gas is formed by the
reaction of the acid with the catalyst, and the resulting
high pressure and temperature conditions within the tube
favoured the addition across the aromatic double bonds•
13Mozingo et al, used ethanol, which is a less strong 
proton donor than acetic acid.
From the results presented, it is possible only to be 
extremely tenuous in their interpretation. More conclusive 
evidence needs to be assembled before the usefulness, or 
not, of this reaction can be ascertained. It does, however, 
present some intriguing possibilities for the specific 
reduction of certain rings in polyaromatic compounds.
1.3*5 Platinum Oxide Catalytic Tritiation of some 
1 5 1 16-Pihydrocyclopenta-/ a 7 -phenanthren-17-ones
A summary of the results is shown in Table 1.8.
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Table 1.8 Details of the PtO  ^catalysed tritiations of Ia-d
Compound ________ Mass_________  Radiochemical
InitiaV Finay ^  Crud^ FinaV % Specific
mg_____ mg Yield Ci Ci Yield Activity
Ci/mmol
Unsubstituted 100 21.2 21.2 11 1.67 15-2 18.3
—17-ketone
(la)
11-Methyl-17- 110 30.4 2 7 . 6 19 5 .91 31.1 47.9
ketone (lb)
12-Methyl-17- 130 64.3 ^9-5 3-5 0.86 24.6 4.3
ketone (Ic)
11,12-Dimethyl- 150 50 33-3 25 10.29 ^1.2 53-6
17-ketone (id)
With such drastic labelling conditions being employed,
3
H-nmr was used to investigate the distribution of tritium 
in the crude and purified products. A summary of the spectra 
obtained, and the solvent used is given in Table 1.9*
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3 1Table 1,9 Details of H and H-nmr spectra of Ia-II
crude
3 1 H-nmr H-nmr
pure
3 1 H-nmr H-nmr
1 Aryl1 
3H-nmr
Unsubstituted- 
17-ketone (la)
dg-Benzene
1.3.5± l-3-5±i
dg-Benzene 
1.3«5iii 1.3«5iv
CDC1
3
1.3.3V
11-Methyl- dg-Benzene dg-Benzene
17-ketone (lb) 1.3.5vi l«3«5vii 1 •3 •5viii
12-Methy1- CDCl^ CDCl^
17-ketone ( i c ) 1.3-5±x 1.3.5x 1.3«5xi 1.3«5xii
11,12Dimethyl- CDCl^ CDCl^ CDCl^
17-ketone (Id) 1.3»5xiii l«3*5xiv 1 * 3 « 5 x v  1 .3 «5xvi 1 .3 . 5xvii
6-Methyl- CDCl^
17-ket9ne (Ie) 1 .3 «5xviii
1,11-Methano- CDCl^
17-ketone (II) 1.3«5xix 1 .3 *5xx
\
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x v i i
XViii
y
xx
Fig 1.3.5i-xx 1HS?H-nmr of la-ll
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1 3The H and H-nmr spectra clearly illustrated the value 
of purification after such drastic exchange conditions.
Some of the impurity peaks are common to all the compounds.
A significant amount of chemical degradation has obviously 
occurred, in addition to probable radioxiecomposition.
3
Assignment of the H-nmr spectra was made with reference
9
to published work, standard compounds, such as phenanthrene,
1 3and the H-nmr spectra. A summary of the H-nmr results
for the purified compounds is given'in Table 1.10.
3Table 1.10 H-nmr data from purified compounds Ia-II
Compound H-Chemical Assignments Relative H
Shifts (ppm) Incorporation
Unsubstituted- 2 . 3 0 16 1 2 . 3
17-ketone (la) 2.59 15 14.2
Fig. 1.3»5iii 7.43 2,3 26.9
0
7.52 12 4.1
7 . 6 2 6,7 13.1
7 . 7 2  , 10.4
4 I
8 . 0 7 4 9.7
8 . 3  4 1 
8.41 J
1 , 1 1 4.1
5.2
11-Methyl-17- to • OJ U3 16 1 6 . 6
ketone (lb) 2 . 6 5 15 15-3
Fig. 1.3«5viii 2 . 7 5 11-Methy1 27.4
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o 7-^3 ( 2,3 7.3
f
7.^5 J 7-3
4 •
7.59 12 ^•5
7 . 6 5 6 8 . 3
7 . 7 8 7 6.4
7 . 9 4 4 5-7
8 . 8 0 1 1 . 2
12-Methyl-17- 2 . 8 0 16 47.0
ketone (Ic) to • 00 4> 12-Methyl 9.3
Fig. 1.3.5xi 3-39 15 8.4
1 •
7.71 2,3 ( 7.8
t ' r S ’ 7.73 J i 7.9
7.85 6 , 7 7.4
7.90 1.9
7-97 4 8.4
8.75 1 1.9
11,12-Dimethyl- 2 . 8 3 16 17.9
17-ketone (Id) 2.91 11 and 12- 31.9
Fig. I.3 .5XV 2.94 Methyl
A 3.38 15 15.1
7.65 2,3 7.2^ ----
5^ T//^ Sni
7 . 6 8 7.1
7.83 6,7 7.7
7.89 4.0
7.98 4 8 . 0
8.75 1 1 . 1
11,12-Dimethyl- 2.92 | 11 and 12- 40.3
17-ketone (Id) 2.95 Methyl
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-'Aryl1 Fig. 3-39 15 13.9
1•3 -5xvii 7.65 2,3 1 0 .8
7 . 6 8 J 11.4
7 . 8 3 6,7 6 . 6
7.90 , 5.1
7.99 4 1 1 . l
8.74 l -Barely Discernable
6-Methyl-17- 2 . 7 8 16, 6-Methyl 2 7 . 8
ketone (Ie) Fig, 3.42 15 15 .6
1.3•5xviii 7.76 2,3 24.6
0 7.92 7,12 12.7
✓ y s -
J ----- — j  IS 8 . 1 5 4 6.9
4 1
8 . 6 8 1 , 1 1
‘
5.1
1
8.79 , 7.3
1,1l-Methano- 2 .8 l 16 8 . 6
17-ketone (II) 3-34 15 1 1 .6
Fig. 1.3»5xix 4.21 -CH2- 22.9
-  fi 7.71 2,3 9.8
—
7.73 12 10.3
4 1 7.87 6,7 1 8 . 5
7.90 4 1 8 . 3
The unsubstituted ketone (la), Fig. 1.3»5i-v shows
reasonably even labelling throughout the molecule. Hindered
positions in the bay-region (1 ,1 1) and next to the ketone
function (1 2) are not well labelled, but the so called
•aliphatic* sites (15,16) have good incorporation. The 
3
H-nmr spectrum following acid treatment (Fig. 1.3.5v),
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obtained in deuterated chloroform is much more compact, 
with some of the aromatic signals being superimposed.
3Similarly, the H-nmr of the 11-rriethyl ketone (lb), Fig. 1.3«5vii
obtained in deuterated benzene, differs markedly from a
9
previously reported spectrum in deuterated chloroform.
Whilst the relative incorporations are similar, the aromatic 
signals are separated better in the deuterated benzene.
The methyl group was highly labelled, and the non-aromatic 
tritium amounted to 59 • 3% of the total. The aromatic 
skeleton was evenly labelled with the exception of the 
slightly hindered 12-position and highly hindered 1-position.
The incorporation of tritium into the labile l6-position is 
most pronounced in the 12-rrtethyl ketone (Ic), Fig. 1.3«5xv, 
where it accounts for k7% of the total. The other aliphatic 
sites account for a further 17 *7%, whilst the remainder of 
the tritium is distributed throughout the aromatic nucleus 
in a similar manner to the other compounds.
The dimethylated ketone (Id), Fig. 1.3*5xv, exhibits a high 
level of non-aromatic-'.labelling. The l6-H was assigned
3
by the comparison of the H-nmr spectrum of the product 
of acid refluxing, Fig. 1.3»5xvi. The aromatic moiety 
was evenly labelled, except for the 1-position. Either the 
6 or 7 position is less well labelled, possibly due to the 
slight hindrance caused by t h e !I)*ring protons at position-15»
73
In the 6-friethyl ketone (Ie) , the signals for the friethyl
—  O
group and / "l6-jh_7 are superimposed, with the total aliphatic 
tritium accounting for k^.k% of the total. Other sites are 
labelled with a similar pattern as found in the previous 
examples.
The 1,11-methano ketone (II), however, displays a different
labelling pattern (Fig. 1.3-5xix), which reflects the high
15
degree of strain in the molecule. The methylene bridge 
is extensively labelled, which might be expected due to its 
accessability. The effect of this 'bridge1 is to distort 
the aromatic nucleus, and thus make the'K-region (6,7) 
less sterically hindered, reflected in the higher relative 
incorporation of tritium.
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2.1 Introduction
As mentioned previously (see p. 9), the 15,l6-dihydrocyclopenta- 
/ a__/-phenanthren-17-ones (I) are structurally related, on 
the one hand, to the classical polycyclic aromatic hydrocarbon
other to the natural steroids. Because a considerable
knowledge of their chemistry, metabolism and biological properties
1
has-been obtained in recent years, they provide an
attractive model for investigating the mechanisms of carcinogenesis
Thus substitution in the parent compound,. which itself is
not carcinogenic, leads to a wide range of biological activity.
The substituted 11-methyl ketone is strongly carcinogenic,
. 2 
being similar in potency to benzo-/ a__7-pyrene (II).
Interestingly bay region substitution is known also to induce,
or enhance carcinogenicity in benz-/ a__7-anthracene (III) ,
chrysene (IV) and benzo-/ a__7-pyrene (II). The 7-methyl
compound in the cyclopenta-/^ a__7-phenanthren-17-one series
is a weak carcinogen, whilst the 2-, 3-» i 6- and 12-frtethyl
1
isomers are inactive. The 11-methoxy compound is almost as 
tumourogenic as the 11-methyl ketone, but other methoxyl 
isomers lack such activity.
carcinogens, such as benzo-/ a 7“Pyr^ne (II), and on the
Attempts at correlating carcinogenicity with the structural 
features of the methyl isomers hare led to X-ray investigations 
With the exception of 11-methylated isomers, all the molecules 
show only small deviations from planarity - in the case of 
the 11-fnethyl ketones, the methyl group causes an out of 
plane deformation of the benzo rings of up to 20.6°. Among 
the other ten compounds investigated, the carcinogens are 
readily differentiated by high angle strain caused by 7- 
or 11-substitution or a 1,11-methano bridge.
As well as using initial state differences, other approaches 
have been employed in attempts to predict which compounds are 
carcinogenic. Thus for some compounds their reactivity 
towards rrialeic anhydride has been used whilst in other 
cases hydrogenation reactions have been employed. Theoretical 
calculations of reactivity have also been used in the same 
way. The presence of a keto group at C-17 points to another 
possibility. As is well known, a C-H bond alpha to a 
carbonyl function possesses weak acidic character, e.g. 
the pKg value of the CH^ group in acetophenone is 19•5-20. 
Similarly the kinetic acidity, that is the rate of ionization, 
can be measured by a variety of techniques, of which halo- 
genation (particularly bromination) and hydrogen isotope 
exchange (usually detritiation) are the most widely used.
In view of the large number of substituted 15,16-dihydrocyclo- 
penta-j^ _a_7“Phenanthren-17--ones available, particularly the 
methyl isomers, the possibility arises of investigating 
the effect of the methyl group substitution on the kinetic
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acidity of the C-l6 hydrogens. In addition there are two 
other aspects that are worthy of study. Firstly the effect 
of aromatic ring stabilisation can be investigated by studying 
the same reaction in compounds (3) and (V-VII). Secondly the 
hydrogens at the position next to the carbonyl function can 
exist in two forms, ec or |3 , using steroid convention* It 
is therefore possible to study stereochemical aspects of 
the exchange process.
VII
Extensive work has been performed on the enolisation of
5 6ketones, both cyclic and non-cyclic in nature. In
particular the simple compounds cyclopentanone (VII) and
Cyclohexanone have been studied in detail in both acid and
base media. Rate constants quoted in the literature for
the deuteration of cyclopentanone vary with catalyst and
7 8solution composition. 1 In a sodium carbonate solution,
the relative rate of deuteration for a number of ketones was
9
estimated as shown in Fig. 2.1i. Acetophenone was also
80
included,-which has been extensively studied by base catalysed 
10 11 12detritiation. ’ * Other work has shown that in--the
presence of an achiral base, then the rate of dedeuteration 
is proportional to the number of isotope atoms present.
However the-use of a monoprotonated base results in two 
different rate constants being observed, with a 70 fold
1 3difference in magnitude. Indanone (VI) has also been shown
9to readily deuterate to 93*5% of the theoretical amount,
kinetic
though no quantitative\data is available•
Fig. 2.1i
No such work has been-reported on the 15*16 dihydrocyclopenta- 
a_J7-phenanthren-17-one (I) series, but some early and
important studies were made by Fishman on both the and p
__ 3 —  1 ^
tritiated isomers of J_ 16- H_/-5<*- Andros tan- 17-one (VIII).
He demonstrated that in'various acidic media, the influence
of the 13-methyl group was sufficient to induce a difference
in rate of detritiation between the <* and 6 positions of ^-l8
This stereoelectronic control resulted in investigations of
model compounds, such as the decalins and 4-tert-butylcyclo-
8i
hexanone (IX), studying the rate of deuteration at positions
adjacent to the carbonyl function. Hydrolysis of the enol
ether of the latter in a AcOD/D^O mixture, gave the original
ketone with the 90% of the isotope in the axial conformation,
and only 10% equatorial. Additionally a rate ratio of
(ax:eq) has been reported for a NaOD catalysed, dedeuteration
15
in J3imethyl sulphoxide-water solution, further illustrating 
the non-equivalence of these protons, and emphasising the 
importance of investigating the reactivity of the u and B 
positions in the 15 , 16- dihydrocyclopenta-/^ a__/-phenanthren- 
17-one series.
PhCO
VIII
IX
In these kinetic studies, the use of non-aqueous solvents 
containing alkoxide ions, greatly enhances the rate of 
detritiation over hydroxide catalysed reactions, due to 
increased basicity. By utilizing a bulky base, such at sodium 
tert-butoxide in dry tert-butanol, any stereochemical differences 
in the substrate tritons will be emphasised. Study of the 
15 , 16-dihydrocyclopenta-/^ a^JZ-phenanthren- 17-ones with these 
conditions should identify any differences in the * and 6 positions.
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2.2 Experimental
2.2.1 Materials
Most compounds were obtained in a pure state as a result of
syntheses performed at the Imperial Cancer Research Fund
Laboratories, e.g. (Xlla-o) . g0th cyclopentanone (VII)
and indanone (VI) were commercially available. Benz-/ e_7r-
indanone (V) was synthesised in an adaptation of the method
21employed by Danneburg and Rahman, and is shown in Fig. 2.2.1i.
R
a, 1-H
b, 1-Me 
0  c, 3-Me
d, 4-Me
e, 6-Me
f, 7-Me
g, 11-Me
h, 12-Me
i, 1,11-CH2 
j, 11-Me & 12-Me 
k, 7-Me & 11-Me 
I, 11-OH 
m, 11-0 Me 
n, 7-Me&11-0Me 
o, 11-Et
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. Aa CHjCHjCi
Fig. 2.2.11
/ p-Naphthoyl /-2-Chloroethane (XIV )
To a cooled solution of naphthalene (25«6g) and ^-chloro- 
propionylchloride (27-8g) in nitrobenzene (60ml, A.R.) was 
added a solution of anhydrous aluminium chloride (32g) in 
nitrobenzene (90ml) over a time of thirty minutes. The 
temperature of the stirred reaction mixture was maintained 
at -5°C - -10°C for four hours, after which it was allowed 
to come to room temperature, and left to stand overnight.
To the resulting dark brown solution, a mixture of concentrated 
hydrochloric acid in ice was added, and the organic layer 
washed to neutral with water. These washings were bulked 
and extracted into benzene, which was then washed until 
neutral. The combined organic layers were steam-distilled 
to remove all the benzene and some of the nitrobenzene.
The remaining solution was left to stand and the light brown 
precipitate that was left was dissolved in diethyl ether 
and dried with anhydrous magnesium sulphate. The ether and 
more of the nitrobenzene were removed by distillation under
reduced pressure at 70°C. The resulting crystals were 
ground with cyclohexane. A sample was then chromatographed 
on silica gel, and eluted with benzene. Initial fractions 
contained an unknown fluorescent compound. The main product 
was taken, the solvent removed, and shown to be a single 
spot on thin layer chromatography.
m.p. 75-79°C (lit80-8l°C)21
mass spec. (m+ )-2l8 ,(m-HCl)-183,(m-CHgCH^C1)-156 
(m-C0CH2CH2Cl )-128 
IR (Nuj ol) - C0= 1678cm” 'L
^H-nmr - 2•8 s(CH2-triplet),3«6 s(CH2-triplet)
7.0-8.25(Aromatic protons).
Benz-/ e /-indanone (V)
/_ p-Naphthoyl__/ -2-chloroethane (4.5g, XIV), was taken and 
mixed with concentrated, pure sulphuric acid (90ml) to form 
an orange solution. After warming on a water bath for 
30-40 minutes, with occasional shaking, the solution turned 
brown, which, on cooling, was added to ice (750g) and left 
to stand. The resulting pale yellow precipitate was extracted 
into benzene and crystalised • The brown solid was purified 
by use of a silica gel column (eluant, dichloromethane: 
toluene, 1:1 v/v). The compound containing fractions were 
combined and thoroughly washed with water. On drying and 
removal of solvent, the product emerged as flight brown crystals 
(0 .9g, 2k%o) which were further purified by recrysta lisation
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from cyclohexane to yield pale yellow needles.
m.p. ll8-119°C (litll9-120°C)21
mass spec. (m+ )-182,(m-CO)-1531(m-C0CH2 )-139 
(m-CH2CH2C0)-126 
IR (Nujol) - C0= 1698cm"*1 
^H-nmr - 2 .826(2H-triplet-2)
3.zt26( 2H-trip let- 3)
7-5-8.ls(Multiplet-6H-aromatic protons)•
2.2.2 Labelling Procedures
The 159l6-dihydrocyclopenta-/ a_/-phenanthren-17-ones,
which were available in small quantities, were tritiated by
dissolving 5-10mg of them in dioxan (A.R.,1.0ml) prior to
the addition of a pellet of sodium hydroxide or a drop of
concentrated hydrochloric acid, followed by tritiated
_ \
water (5^1i 50Ci ml ). This mixture was left at room 
temperature for 2-3 days whereupon the labelled product was 
extracted into chloroform or ethyl acetate, dried over 
anhydrous sodium sulphate, and the solvent removed by freeze 
drying. The product was dissolved in deuterated solvent 
(50^il, usually CDCl^) , the radioactivity determined, and
o
if sufficient (>lmCi) subjected to H-nmr analysis. In 
some cases the base catalysed procedure led to some by­
product formation. For these compounds (XIIa,g,h, i), 
further purification was effected by thin layer chromatography. 
In general the acid catalysed procedure caused less by­
product formation.
4-Tert-butylcyclohexanone (XI), indanone (VI) and benz-
/ e / -indanone (V) were tritiated by the base catalysed
method, whilst the method used for Cyclopentanone (VII)
22 21was similar to that used for its deuteration, 1 J as more 
drastic conditions led to the formation of other products. 
The compound (200jj1), diethyl ether (A.R.,0.5ml), tritiated
_ i
water (lO|il,50Ci ml ), potassium carbonate (A.R.,8mg) 
and sodium chloride (A.R.,*tOmg) were placed in a sealed 
tube and the contents kept at room temperature for two 
weeks. Additions of water, followed by extraction with 
diethyl ether, drying over anhydrous sodium sulphate, and 
removal of the solvent by the slow passage of a stream of 
nitrogen over the surface of the solution gave the required 
product•
2.2.3 Kinetic Methods
The method used is similar to that employed to study the
10 11 12detritiation of acetophenone, and related compounds. ’ 1
Due to the insolubility of the 15,16-dihydrocyclopenta- 
r * j  -phenanthren-17-ones, the hydroxide catalysed reactions 
were performed in a water-dioxan mixture (90:10, v/v) , 
which for consistency was retained for the more soluble 
ketones. For the non-aqueous solvent detritiations, a 
solution of sodium tert-butoxide in dry tert-butanol was 
used (0.00152M). Solutions were equilibrated at 25«0°C
in a thermostated water bath before the addition 
of trace levels of the radiolabelled compounds, as solutions
in dioxan. This mixture was vigorously shaken, to ensure
homogeneity. Samples (5ml) were withdrawn at fixed time
intervals and injected into tubes containing scintillator 
_ y
(10ml; 3.4gl 2,5-diphenyloxazole in toluene) and water
(10ml). Each tube was then shaken, and left to stand. 
Following separation the toluene layer was removed,dried 
(Anhydrous Na 2^ 4  ^ and the radioactivity of a portion (5ml) 
determined.
TThe first order detritiation rate constants (k ) were
Tcalculated from the slopes (-k /2 .303) of the plots of log
_ y
(counts min ) against time and by dividing this value by
the concentration of the hydroxide ion, the second order
rate constant ( k][„-) was obtained. A typical analysis,
U n
using the data for 15 , 16- dihydro , - 1-methylcyclopenta-/^ a__7 - 
phenanthren-17-one (Xllb) is illustrated in Table 2.1.
Temperature = 25«0°cio.l°C 
Concentratiorj. of NaOH Solution = 0.2099M
Time (min) Radioactivity (counts/min) log^Q ^oouiits/min)
0 643700 5.809
1 500400 5.669
2 387900 5.589
3 309400 5.^91
4 243100 5.386
5 191100 5.281
6 148100 5.171
7 117300 5.069
88
8 91800 4.963
9 735 00 4.866
10 58000 4.743
11 46900 4.671
Table 2. 1.
The plot of log^Q (counts/min) against time is shown in
fig. 2 .2 .3i, which gave a correlation coefficient of
- 1
-0.9999i the gradient being -0.1039min • This therefore
T - 3 -1 . Ttransforms to a k value of 3*99x10 sec • The k - valueOH
is therefore 1.90x10 ^sec Usually 3-6 experiments
were carried out at different sodium hydroxide concentrations 
( 0.1-0.3M) .
The uncertainty in the values of k^- for the simple ketones 
(V-VII) amounts to - 2-4%, which is comparable to those 
obtained in similar studies. For some of the 15 ? l6-dihydro- 
cyclopenta-/-a_J7-phenanthren-17-ones , the uncertainty is a 
good deal higher (i 10%) and this could be associated with 
the difficulties encountered in the base catalysed tritiations.
89
Fig. 2.2.31
Treatment of the raw data from the detritiation of 4-tert-
butylcyclohexanone (XI) was more extensive, as two parallel
reactions were occurring. As in the simpler single detritiation,
a plot of log^Q (counts/min) against time (min) was made.
A typical graph is shown in fig. 2.2«3ii* A curve fitting
computer programme was used to optimise the results. The
gradient of the latter part of the curve could be transformed 
Tto a k value equivalent to the slower of the two rates
T —4 —1(kg^-1.6 7x 10 Mec-l), as the faster reaction is complete at
this stage.
90
The value of counts corresponding to the first, more reactive 
site was obtained by removing from the initial part of 
the curve, that proportion of the counts present in the 
second less reactive site. This was achieved by extra­
polating the straight line back to t=0, and reading off values 
of the counts (by finding the antilogarithm) associated with 
the second site at ten time points on the line. Similar 
treatment of the curve at the same time points will give 
the total counts present, and thus by difference, the counts 
in the faster reacting site may be determined. A plot of
_ i
the log^Q of the newly obtained values of counts min 
against time (min) will yield a straight line graph (fig
2.3»3iii) which may treated as before to give the faster
T -4 -1
rate constant, k-j (4.63x10 sec ). The second order rate
T
constants (]&H- ' may be found as previously described 
(0.12x10 ^m *sec"’* and 0 . 33xlO_^m” *sec~ * ) •
e-5
frO
0020019010050
Fig. 2.3* 3ii
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2.3 Results and Discussion
All the ketones labelled contained sufficient radioactivity
for H-nmr analysis to be performed, except for the 4-methyl-
(Xlld), 11,12-dimethyl- (Xllj), 7,11-dimethyl- (Xllk) and
11-hydroxy- (XIIl) derivatives of the 15,l6-dihydrocyclopenta-
/ a /-phenanthren-17-ones. The usefulness of this technique
in assessing purity may be illustrated inithe proton decoupled
spectrum of the product of base catalysed tritiation of the
carcinogenic 11-methylketone (Xllg), where the presence
of an impurity ( 6 = 2 .0 7 , 11%) is readily seen, fig. 2 .3i)»
1
Purified products gave a single sharp line in the H-decoupled 
tritium spectra ( s= 2.70-2.8 6 ,CDC1^)• Cyclopentanone (VII) 
was the only compound where the spectrum was obtained from 
a neat liquid ( 6 = 2 .0 3 ) •
3
The only compound not to give a single sharp line after H-nmr 
analysis, was 4-tert-butylcyclohexanone (XI), where a pair 
of peaks ( 6 = 2.29, ^3%i Equatorial and s= 2.37, 57%, Axial) 
resulted. (Fig. 2.3ii«)
In the kinptic study, good linear first order plots were
obtained, thus showing that the exo- and endo- forms of the
C-l6 hydrogens are equivalent and equally reactive. The
change from a purely aqueous medium to the water-dioxan
system is unlikely to have a large effect on the rate. This
was confirmed when comparing the value of kJTJ- forOH
— 3 — 1 — 1
acetophenone in both the 10% dioxan mixture (5 .81x10 m sec )
93
— 3 — 1 — 1and the simple aqueous system (5-50x10 m sec ). The 
difference is only 5-6%*.
2-776
2-076
Fig. 2.3i
9 7 5 08 6 3 2A
Fig. 2.3ii
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The rate constants for the compounds studied are given in 
Table 2.2.
Compound T 2 T 2k  - x lO Average ^q h ~ xlO■OH*
— 1 — 1 — 1 — 1( M s e c  ) ( M s e c  )
Unsubstituted (Xlla)
1-Methyl (Xllb)
3-Methyl (XIIc)
4-Methyl (Xlld)
1 . 7 0
1.79
1 . 8 3  
1.75 
I . 85  
1.94 
1.97 
1 . 8 1
1 . 8 0
1 . 8 3  
1 . 9 0
1 . 8 3  
1.90
1.41 
1.44
1.41 
l .4l 
l .44 
1.35 
1 . 2 3  
1.53 
1.55
1 .8 3^0 . 1 4
1.8 5-0 . 0 5
1.42-0.02
1.47-0.19
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6-Methyl (Xlle)
7-Methyl (Xllf)
11-Methyl (Xllg)
12-Methyl (Xllh)
1,11-Methano (Xlli)
11,12-Dimethyl (XIIj)
1,66 
1.37 
1.58 
1.01 
1 . 1 3  
1.17 
1 .2 9  
3.09 
3.12 
3.23 
3.22
1.46
1 . 5 1
1.41
1.46 
1.44
1 . 5 2  
0.74 
0 . 6 3  
0.66 
0 . 6 5  
0 . 6 9  
0 . 8 5
0.95
0 . 8 3
0.86
0 . 3 4
0 . 3 2
1.1 5 1 0 .1 4
3 .17^0 . 0 8
1.47-0.06
0 .6 7^0 . 0 7
0 .8 7^0 . 0 7
0 .3 0 1 0 . 0 5
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0.31
0.27
0.29
0 . 3 0
0.25
0.29
7,11-Dimethyl (Xllk) 2.62 2.45^0.19
2.36 
2.26
2.54
11-Hydroxy (XIII) 0.21 0.2 3±0.02
0.24
0.23
0.24
11-Methoxy (Xllm) 2.04 2.06^0.06
2.03 
2.06 
2.12
7-Methyl,11-Methoxy (Xlln) 2.46 2.50±0.17
2.42 
2.67
2.43
11-Ethyl (XIIo) 1.55 1.58^0.03
1.57
1.58 
1.60
Cyclopentanone (VII) 0.64 0.65-0.02
0.67
97
0.67
0.63
Indanone (VI) 2.42 2-37^0.09
2 . 2 8
2.40
2.37
Benz-/ e_/-indanone 1.17 1.12^0.05
1.07 
1.14
1.08
4-tert-Butylcyclohexanone (XI) 0 . 36 , 0.11 0.34^0.02
0 .3 3 , 0 . 1 2  0 .11^0 . 0 3
0.34, 0.09 
O.3 3 , 0.14 
0.34, 0 . 1 2
Table 2.2.
In a fully aromatic structure, delocalisation of charge 
thorough resonance is usually an important factor in stabilising 
carbanion formation and hence increasing carbon acidity.
When the planarity of the system is disturbed or removed, the 
stabalizing effect is greatly reduced. In the partly aromatic 
compounds studied here, steric strain, induced by deviations 
from planarity and shown by X-ray crystallography, are probably 
the cause of the anomalous reactivity patterns observed.
Previous X-ray studies on the parent ketone (Xlla) showed
it to be essentially planar, with no unexpected distortion
of the phenanthrene moiety. The rate constant ( kXu-)OH.
may then be taken as the base value for the compounds in 
this series. The non-carcinogenic 1-rriethyl compound (Xllb) 
has only recently been synthesised, and its effect in 
biological systems is currently under investigation. The 
rate of detritiation is the same as that of the parent ketone.
Any inductive effects are likely to be small as the methyl 
group is far from the point of ionization. The suggestion 
is that the compound is similar to the unsubstituted ketone 
in its behaviour in solution.
The 3- and 4-methyl (XIIc, Xlld) ketones may be considered
together. Although no X-ray data is available on them,
results from the isomeric 2-rrtethyl compound show a planar
structure. With the methyl groups in similar positions, it
is probable that they would also have no affect on the planarity
of the system. These groups would not restrict any dynamic
movement of the phenanthrene nucleus. The kITJ- values are
Ori
2 0-23% lower than for the parent ketone, consistent with the 
weakly electron donating properties of the methyl groups, 
coupled with the relatively large distance from the ketone 
function.
The substituent effects are more pronounced in the 6-methyl isomer 
(Xlle) as might be expected, as the point of substitution
3
is nearer to the ketone group. In the crystallographic studies, 
the compound shows the minimum deviation from planarity (l.5°)«
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It is therefore unlikely that a large distortion of the 
aromatic nucleus is responsible for the reduction in the 
rate of detritiation•
The isomeric 12-m3thyl ketone (Xllh) has a very low rate of 
detritiation, similar to that of cyclopentanone. However it 
is unlikely that there is no contribution for stabilisation 
from the aromatic nucleus. The substituent inductive effect 
will destabilise the enolate anion, thus slowing down the 
reaction. It is also possible that the methyl group will 
sterically interact with the enolate anion, causing further 
destabilisation, fig. 2.3iii»
Fig. 2.3iii
The kinetic data for both of the carcinogenic 7-methyl and
11-methyl ketones were obtained. Whilst the 11-methyl isomer 
has a lower reaction velocity than the parent letone, the 
7-methyl ketone exhibits a dramatic rate enhancement.
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19Difficulties experienced in synthesising the latter compound 
are suggestive of steric crowding in the region of the methyl 
group. X-ray crystallographic studies confirmed this, with 
the very close approach of the methyl protons to the methylene 
protons at position 15- This is illustrated in fig. 2.3iv.
a -1-820 A 
b-1-844 A
H
Fig. 2.3iv
The kinetics would suggest that the rate enhancement is due 
to an interaction of the methyl and methylene protons• It 
is probable that they act as a "locking" mechanism, preventing 
either rotation of the methyl group, or the possibility of it 
moving either above or below the plane. By being held in 
this conformation, planarity is retained, thus stabilising 
the carbanion formed during detritiation. Furthermore this 
effect dominates over inductive effects as the rate is
1.7 times that of the unsubstituted ketone (Xlla).
As expected the 11-methyl compound does reduce the 0^H~*
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value when compared to the parent ketone. However this is 
not as great as may be expected, with the methyl group V 
to the point of enolisation, when comparing the value of 
the p-substituted ketone (12-methyl, Xllh) . This does imply 
that 12-methyl substitution does have a steric interaction 
with the enolate anion.
Similar effects may also be seen in the disubstituted compounds. 
7-methylation consistently enhances the rate, with the 7111- 
dimethyl- (Xllk), and 7-methyl,11-methoxy- (Xlln) compounds
exhibiting similar kj_.- values. In both cases the rate
U r i
is reduced from that of the monomethylated species, due to 
the inductive effect, and possible distortion, of substituents 
at position 11. Once again the 7-methyl group dominates 
the kinetics of detritiation of these molecules.
The 11,12-dimethyl- compound (Xlli) shows extensive rate 
retardation, with the ^5% of the value for the
12-methyl compound. The presence of two methyl groups and 
the crowding of the region in the 'C' ring of the molecule 
will reduce the stability of the anion by inductive means, 
and almost certainly by severe distortion of the aromatic 
moiety.
Possibly the most surprising feature of this kinetic study 
was the extreme retardation of the rate, compared with the
parent ketone, of the 1,11-methano- compound (XIIo). The
3
crystallographic work previously performed had shown a
highly strained aromatic system, which was nevertheless
held rigidly within a plane. It is possible that in addition
/
to the expected inductive effect, the high degree of strain 
and distortion in the phenanthrene nucleus allows much 
less favourable orbital overlap within it.
The ll-'ethyl- compound (Xlln) shows a similar rate constant 
to the 11-methyl- compound. Slight enhancement may be due 
to the natural orientation of an ethyl group, where only a 
CH^ group is required to occupy space within the !bay region1, 
thus reducing slightly the steric crowding.
The presence of small electron withdrawing groups at the
11-position in this series of compounds does not inhibit
carcinogenesis. The 11-hydroxy compound (Xllk) is too
insoluble to be tested normally by skin tests, but is tumouro-
1
genic when injected intraveneously. The 11-methoxy compound 
(XIII) induces tumours to an Iball Index value of 72% of 
the 11-methyl ketone (Xllg)• The electron withdrawing nature 
of the methoxy group helps to stabilise the enolate anion, 
thus increasing the rate of reaction over the parent compound.
The results for the 11-hydroxy ketone (Xllk) show that the 
detritiation rate is the slowest of all the compounds investigated. 
This finding is consistent with the fact that under the 
conditions of high pH used in the study, the group will be 
ionised, and thus the compound reacts as the anion.
The influence of the benzene rings on the detritiation can
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best be seen when comparing the values for kJTT- of cyclo-Orl
pentanone (VII) and indanone (VI). The four-fold acceleration
of rate is probably attributable to the extra rigidity
provided by the aromatic ring. It is interesting to speculate
as to whether the addition, in a linear manner, of a second
benzene ring would continue this trend. The preparation of
the benz-/ e__/-indanone was to study the effect of increasing
the number of rings singly to the parent 1 5 ,l6-dihydrocyclo-
penta-/ a_7-phenanthren-17-one (Xlla). The rate constant
showed a two-fold reduction in rate from the indanone. The
addition of the final ring to give the uasubstituted ketone
(Xlla) brings with it a 6 0% increase in kju-.OH
Therefore the effect of these additional rings is not simply 
additive, but depends on factors such as deviation from 
planarity, which in themselves are a cause of ring strain.
The detritiation of 4-tert-butylcyclohexanone reflects other 
published work on the effect of the tert-butyl group as a 
conformational anchor in this compound. Because of the 
lack of ring inversion, the axial and equatorial tritons are 
readily distinguishable, which is reflected in the detritiation 
kinetics. The ratio of rates is (ax:eq), which is just
sufficient to enable the calculation of both the rate constants 
by graphical methods .
The ratio of the two rate constants is similar to the 
dedeuterations studied in a sodium deuteroxide in dimethyl
104
15sulphoxide solution. The results from this compound 
emphasises that axial and equatorial tritons may be identified 
by such kinetic studies. That no such distinguisability could 
be found in the 1 5 » l6-dihydrocyclopenta-/ a__/-phenanthren- 
17-ones series, suggests that the c<and p-tritons are identical, 
or so similar as to appear to be under these conditions.
The effect of nonaqueous solvent detritiation of the 15,l6-
dihydrocyclopenta-V a /-phenanthren- 17-ones -was briefly studied.
For both the compounds studied, the parent ketone (Xlla)
and the 11-ethyl ketone (XIIo) displayed straight line first
Torder kinetic plots, -with rate constants (kg^tg- ) of 0.48 
— 1 — 1and 6.74M sec respectively. These results further confirm 
the indistinguisability of the l6-«< and l6-p tritons in the 
15 *l6-dihydrocyclopenta-/ a /-phenanthren-17-one series.
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3.1 Introduction
Various substituted 15 il6-dihydrocyclopenta-/ a_7-phenanthren-
17-ones (I) have been shown to have different carcinogenic
and mutagenic properties when tested on mice, with cell
1—4cultures and bacteria.
a, R=R1 = H
b, R=Me,Rf=H
c, R =H , Rj=Me
d, R=R1 = M e
That the biological activity of these compounds is dependant
upon a change in their nature has been clearly demonstrated
by the examination of the DNA-adducts formed from them, and
also the necessity of a metabolising system to induce mutagenesis 
5 6in bacteria. ’ To characterise the changes in the nature of 
these compounds, and hence understand the requirements for 
tumour f/genesis, it is necessary to identify the various 
derivatives formed in vivo. The study of such a process is 
particularly difficult, due to the complexity of the system, 
especially as biological macromolecules are abundant, to 
which many metabolic products are likely to bind.
In the case of the 1l-rttethyl-17-ketone (lb) the major urinary
110
metabolite in the rat has been identified and characterised
7
as an .epoxytrihydroxy-benzocyclodecane (II). A recent study 
of the metabolism in skin of the related compound 5-i**ethyl-
g
chrysene (III) has been performed, though this is costly in 
both time and animals.
0
OH
OHHO
In order to study the likely nature of the metabolites formed,
in a relatively simple manner, an in vitro method has been
established, utilizing a rat liver microsomal preparation
(9000g supernatant) as the enzyme system. This has already
been used to study the metabolism of the 1 1-ftiethyl-17-ketone
(lb) , and other compounds in this series.^’^ ’^ ’^ ’^  Individual
metabolites have been characterised, and for the 11-rriethyl
compound (lb), the carcinogenic activity of them has been
10established in animal tests.
Differences in the carcinogenic activity of compounds in this 
series may be related to their ability to produce certain 
metabolites. Thus a study of the in vitro metabolism of a 
number of them will determine if some metabolites are peculiar 
to the carcinogenic compounds.
Ill
The biological activity of those compounds chosen is very
varied. Whilst the 11-niethyl ketone (lb) is both strongly
mutagenic and carcinogenic, the parent ketone (la) is not
carcinogenic, but exhibits a marked level of mutagenic activity
k
in bacterial tests. The 12-methyl-ketone (Ic) appears to
12show no significant activity in either test. The 11,12- 
dime thyl-ketone (Id) is active in both tests, though to a 
lesser extent than the 11-methyl compound (lb).
Previous -work has identified the 11-friethyl, 3 , k- dihydrodiol (IVa)
10as the proximate carcinogen, which was shown to lead to an
anti,314-trans-dihydrodiol-1,2epoxide (Va), the ultimate 
9
carcinogen. The same configuration has been observed in the
4
metabolism of the 12-inethyl ketone (iVb, Vb). The unsub­
stituted ketone (la) however, shows an adduct derived from 
a syn-3i4-trans-dihydrodiol-l,2-epoxide (tfx)» in itself derived 
from a 3,4-trans-tiihydrodiol.
a, R = M «,B 1=H
b, R = H ,R 1=M e TlOH0‘
HOHO
HO
HO
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For each of these compounds, the major metabolites have 
been identified and simultaneous experiments performed, under 
identical conditions, to determine the relative quantity of 
each formed. Of particular interest were the 3,4-dihydrodiols, 
which in the 11-methyl ketone is the proximate carcinogen.
Normal biological activation of these compounds involves
1,2-epoxidation prior to DNA binding. It was originally 
thought that this would mitigate against carcinogenicity in
the 15,16- dihydro-1,11-methanocyclopenta-/ a_/-phenanthren-
1 317-one (Bridge) compound (VII). This was not, however, 
found to be the case, and 1,2-epoxidation, together with 
carcinogenicity was observed with this ketone. Initial work 
on the 1-methyl ketone (VIII), has not shown it to have 
any significant tumourogenic capacity. In vitro studies were 
therefore performed to determine the pattern of metabolites, 
and specifically the blocking effect, if any, of the methyl 
group on 1 ,2-epoxidation.
VIII.VII
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3.2 Experimental
3.2.1 Materials
The 15 » l6-/Jihydrocyclopenta-/^ a /-phenanthren- 17-ones were
all obtained in a pure state from the Imperial Cancer Research 
Fund Chemistry Laboratories. Radiolabelled compounds were 
prepared as reported in Chapter 1. All other chemicals were 
commercially available.
3.2.2 Preparation of Rat Liver Homogenate
Sprague-Dawley rats (75-150g) were given intraperitoneal 
injections of 3-methylcholanthrene (lOmg/kg) prior to fasting 
overnight, and sacrifice by stunning followed by cervical 
dislocation. The livers were removed and immediately homo­
genised in ice cold sucrose solution (O.25M, 2ml/g of liver). 
After centrifugation at 9 ,000xg for fifteen minutes, the 
supernatant was stored in 2-ml screw-top plastic vials at 
-80°C until required.
3.2.3 Preparation of Microsomal Pellets
The required number of tubes of rat liver homogenate were 
taken, thawed out, and spun in 10ml screw top tubes (Oak Ridge, 
Polycarbonate), in an M.S.E. centrifuge with a lOxlOTi 
rotor, maintained at a temperature of 0-5°C, at 15K rpm for 
30 minutes. The supernatent was then transferred to 10ml,
Ilk
metal capped M.S.E. tubes, and centrifuged for 45 minutes 
at 35K rpm, maintaining the temperature previously used.
The resulting pellet, -which contained the microsomal enzymes, 
was then resuspended in tris buffer (0.1M, pH7«2, 1.0ml),
using a hand homogeniser.
3.2.4 Conditions of In Vitro Metabolism
Slight variations in the activity of the enzymes were noted 
with different batches of homogenate. Enzyme/substrate 
proportions were therefore adjusted to maintain a consistent 
level of metabolism. Typical conditions are outlined below. 
To NAPDH (l9-20mg) in tris buffer (pH7«2, 3-0ml) wa® added 
the compound (l^imol) dissolved in dimethyl sulphoxide ( 50j l i1 )  .  
Finally the microsomal fraction was added, and the mixture 
shaken at 37°C, open to the atmosphere, for half an hour.
The reaction was stopped by the addition of ethyl acetate 
(A.R., 5*0ml). After shaking, the organic layer was removed. 
A further five extractions were performed, after which all 
the ethyl acetate solutions were combined, dried (anhydrous 
sodium sulphate), and the solution decanted into a separate 
flask. The solvent was removed under vacuum, and the 
resulting gum dissolved in methanol (A*R., 100 ijl) •
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3*2.5 Chromatographic Separation of Metabolites
High .performance liquid chromatography (H.P.L.C.) was used 
(Waters Associates, MA, USA). The methanol solution was 
added to a Whatman Partisil M9 10/50 ODS column (Whatman 
Ltd., Maidstone, UK), and eluted with a solvent system of 
15% methanol in water, changing to 100% methanol over 80 
minutes, flowing at four ml per minute. Products were 
detected by ultra-violet absorption at a wavelength of 
25^tnm. Any alterations to these conditions are given in 
the text, where appropriate.
3.2.6 Identification of Metabolites
Metabolites were collected and their ultra-violet spectra 
determined. Sodium borohydride was added to each of the 
solutions, in the U.V. cells to obtain spectra of the compounds 
where the ketone function at position 17 has been reduced 
to a hydroxyl group and where phenols were expected, two 
drops of sodium hydroxide solution (dilute) were added to 
obtain the ionized spectra. Where necessary, the radioactivity 
was determined by removing aliquots (50yul), for liquid 
scintillation counting.
For bulk preparations of metabolites, each product was 
collected and re-run on H.P.L.C., prior to mass spectral analysis, 
where the dried samples were sent for analysis in sealed tubes.
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3.3 Results and Discussion
A summary of the results is given in table 3-1-
Table 3.1 Details of in vitro metabolisms
Separation
Conditions
Standard
Standard
Standard
Standard
Compound
I-Methyl (VIII) 
Unsubstituted (la)
II-Methyl (lb) 
12-Methyl (Ic) 
11,12-Dimethyl (Id)
Quantity 
Used (|imol)
H.P.L.C. Ref 
Number
3-3-li 
3-3-3i 
3-3-5i 
3-3-2i
3-3-^i
a 30% Methanol/Water to 70% Methanol/Water over 3 hours 
at ^mlmin
3.3*1 In Vitro Metabolism of 15 , l6-Pihydro x- 1-methylcyclo- 
penta-/ a /-phenanthren-17-one
Using standard chromatographic conditions on the metabolites, 
of this compound, revealed a great number of peaks almost 
coeluting. On adjustment of the solvent gradient, a satisfactory 
separation -was achieved (Fig. 3-3-li)-
Under these improved conditions, the peak M, of microsomal 
origin and always found in such experiments, proves to be a 
good internal reference point, together with the unchanged 
compound, with the varied chromatographic conditions. The
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unchanged compound (VIII) is the final fraction to elute 
from the column, as the least polar constituent. Those 
metabolites eluting prior to M, may be denoted as various tetraols 
and pentols•
e l
40 60 80  100 120 140 160 180 200  220 240 260 280  3 00  320 340 30C
ELUTION VOLUME/ml
Fig. 3 .3 .li
Metabolites from the ll-ittethyl compound (lb) have been
9 11extensively studied, r and the stereochemistry of the various
'4
products established by ultraviolet, mass spectral, nmr and 
elution time evidence. Additionally, a study of the adducts 
formed -with DNA, has yielded valuable stereochemical
4 9 11information. 1 ’ This wealth of knowledge provides a
basis for the interpretation of data for similar compounds.
For the 1-methyl compound, a summary of the ultraviolet results 
are given in table 3 *2 .
Table 3*2 Ultraviolet spectra of 1-Methyl ketone Metabolites
Fraction Assignment
+BHZt“ +0H”
M
a 259 ,277sh 
2 9 0sh , 301 
2 6 8 ,304sh 
331,337 
350sh , 368 
268,279 
298
264,297
2 7 0 , 3 0 2  
359,376 
2 6 8 ,302sh 
355sh,369
236.259
258,267
296,305
257,266 
2 8 2sh,294 
30 3sh
267,273 
284,293 
259,282 
2 9 2 ,304
251.259 
303sh , 3 6 3
Microsomal 
A-ring Metabolised
1,2,15-Diequatorial 
Dihydrotriol
Methyl,15,l6-Triol
258,293 Methyl,15/l6-Diol- 
4-phenol
Methyl,15/l6-Diol 
15 ,16-Diol
119
h
m
254,278 
30 3
243,267
293
2 5 2 , 2 7 6  
299
249,282 
2 9 6sh, 
3l8sh,346
365,3&5sh
237,248 
258sh,28l 
291
247,258 
2 6 6sh 
2 9 2sh 
2 5 8 ,2 8 lsh 
2 9 2sh,304
26l ,290 
324,385
15/16-Mono1-4- 
phenol
262,291 Me thy1-mono1-4- 
phenol
266 ,2 8 8sh 
302sh , 357 
373
2 7 0 ,2 8 5sh 2 5 6 , 2 8 1
303sh, 358 2 9 2 , 3 0 3
375
2 6 8 ,2 9 0sh, 2 5 6 ,2 7 3sh,
303sh
268,290sh Diphenol 
30 lsh
15-Monol
Methy1-mono1
l6-Monol
2 7 2 ,304 260,284
327
4-Phenol
282 ,292 
305 
2 5 0 , 2 8 3  
2 9 5sh , 318 
344,363
The spectra are shown in Fig. 3-3«lii, together with the 
proposed structures of the metabolites.
------------  original
-----------+BH4
-------------+OH"
120
258
267
HO. OH
331
.350
368
259
!77
290
264
297
■OH
OH
298
■OH
268
257/ OH
279
\2 6 6
\  303
282
\ 294
121
259
258
164
OHOH
297
OH
302
282 V 359 376
OH278
303
282
346
365
385318
268
259
2 5 1 /1
OH
OH
301
369
303
122
267243
?4J/
\_ ? 5 8
293
261
'OH
OH
324 385
290
DIPHENOL
252 •
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123
\281 OH
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375
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268
256
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270
290
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260 P 2
304
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Fig. 3.3.lii
Within this series of compounds, 1,2-dihydrodiols exhibit
a 1,2-diaxial conformation to minimize steric crowding. This
is found whether or not there is a methyl group at position 
13-11 (IX). This particular conformation is more polar than 
diequatorial arrangements , thus favouring earlier elution from 
the reverse-phase H.P.L.C. column.
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In the case of the 1-rrtethyl compound, metabolite b appears
to be the 1,2 ,15-dihydrotriol, with the 1,2-dihydrodiol,
taking up a quasi-diequatorial conformation, the methyl
group being found arranged axially (X). The retarded retention
time illustrates the difference when compared with the
quasi-diaxial conformations found in other triols in this
series. A precedent for this does exist in the metabolism
of the 1, 11-rriethano- (Bridge) compound (VII), where, amongst
other products, the quasi-diequatorial 1,2 ,15- dihydrotriol 
lk
is found. For such compounds, ultraviolet evidence 
readily reveals the 1,2-dihydrodiol system, with the character­
istic double peaks 2^0nm) in the borohydride reduction 
spectra.
Finding such a metabolite shows that a 1-methyl group does not 
totally inhibit 1,2-epoxidation. Further evidence of such 
oxidation is found in the early eluting fractions (e.g. a), 
which display ultraviolet spectra typical of naphthalene 
conjugated ketones, suggesting a completely saturated 1 A*-ring. 
As with the 12-methyl isomer (see 3*3-2)t the retention time 
suggests some conjugation of the resulting tetraol, thus 
reducing its polarity.
Me
X
OH
If the 1-methyl compound is metabolised in a similar manner 
to its 11 and 12-methyl isomers (la and lb), then any 3i4,15- 
and 3,4,16-dihydrotriols, existing in a predominantly quasi- 
diequatorial conformation, might be expected to elute at a 
similar time to the quasi-diequatorial 1 ,2 ,15-dihydrotriol
(b). However, the ultraviolet evidence presented onmetabolite
(c), suggests retention of the phenanthrene nucleus. With 
such a retention time, the assignment of methyl,1 5*16- triol 
may be given, the 1 5?l6-diol system slightly reducing its 
polarity by intramolecular hydrogen bonding.
Ultraviolet data on the basic solution of metabolite (d)
clearly indicates the presence of a phenol. Retention time
evidence suggests a diolphenol. From the level of methyl
group hydroxylation in other metabolites, it is probable that
an assignment of methyl,15 or l6-4-phenol may be given. Almost
certainly the spectra shown are of a mixture of the 15 and
16 hydroxylated isomers. The chromophore of some synthetic
154-phenol is very similar, enabling the position of the 
phenol to be assigned.
Methyl hydroxylation again dominates in metabolite (e). It 
would appear to be either the methyl , 15 or methyl,l6-diol, 
though it may be a mixture, as all three possible monols are 
formed (j-l), which may presumably be further metabolised. 
Ultraviolet evidence clearly demonstrates the presence of 
the intact phenanthrene nucleus.
127
The phenanthrene chromophore is again present in metabolite 
(f), where there also appears to some intramolecular hydrogen 
bonding (XI) due to the adjacent hydroxyl groups in the 
15, l6-ldiol • This hydrogen bonding lengthens the retention 
time over the other diols (e). Interestingly, the only 
unequivocal evidence of a 1 5,16-diol in this series occurs 
with the parent unsubstituted ketone (la, 3»3-4).
Unlike other compounds in this series, there is no evidence
of any 31 dihydrodiols being formed. It would appear that
either any produced is dehydrated to yield the 4-phenol, or
the epoxide is directly rearranged to the phenol. Electron
release of the para-methyl group may promote isomerisation,
15
as electron withdrawal tends to stabilise epoxides. An 
enzyme, epoxide hydrase^ is known to be required to convert 
the epoxide to the trans-dihydrodiols.
It is probable that rearrangement occurs before the enzyme 
can act. A precedent for such a rearrangement does exist, 
as naphthalene-1,2-oxide (XII) has been shown to spontaneously 
transform, at physiological pH, with an associated hydride 
shift, to the 1-phenol (XIII
128
OH
Metabolites (gj) and (h) show this 4-phenolic chroraophore, 
and retention times typical of rtiono-phenols. Assignment was 
made by a study of the minor bands in the ultraviolet spectra.
The methyl hydroxylation is again extensive, illustrated by 
the quantity of (h) formed.
spectrum
The ultravioletj^of compound (i) in basic solution, shews that it 
is phenolic. However the X max values are different from 
the synthetic 4-phenol, and the retention time suggests a 
diphenol of some sorts. The most likely candidate for this 
would be a 2,4-diphenol, resulting from rearrangements firstly of 
the 3,4-epoxide, and then the 1,2-epoxide. There are however 
no synthetic samples of the 2,4-diphenol to compare it with, 
and there is no other evidence of a 2-phenol in this series.
Metabolites (j-1) are the three mono-hydroxylated compounds, 
with the hydroxyl groups found in the aliphatic positions•
The fnethy 1-hydroxy compound (k) is the most abundant. The 
15-monol (j) is present only in small quantities, but appears 
to further metabolise to a greater extent than the l6-monol (1 ), 
probably being a better substrate for the enzyme site.
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The 4-phenol (m) is found, as expected, eluting after 
the three monols (j-l). It is not present in large quantities, 
but the amount of other metabolites containing the 4-phenol 
function, suggests that it is a very good substrate for 
further enzymic oxidation.
Overall, a complex pattern of metabolism has emerged -with 
two important features. In particular, despite the presence 
of a 1-ifiethyl group, 1 ,2-epoxidation and hydrolysis, does 
occur. The methyl group does however appear to dictate a 
change in the stereo-chemical conformation in the products, 
from that usually found.
Additionally, a 3 ,4-dihydrodiol is not found, the 4-phenol 
being derived instead from the epoxide. This would almost 
certainly prevent any DNA binding in an analogous manner to 
that of the other compounds in this series. This could be a 
reason, though not necessarily the only one, for the lack 
of tumoorogenic activity in this compound. A summary of 
the metabolism is given in Fig. 3«2.1iii
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Fig. 3*2.liii
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3.3*2 The In Vitro Metabolism of 15»l6-Pihydro-12-Methyl- 
cyclopenta-/ a /-phenanthren-17-one
A previous study of the metabolism of this compound (Ic) ,
utilizing a rat liver microsomal enzyme system, has shown
k
a limited number of major metabolites. One of these was
identified as a trans-3 1 dihydrodiol, on the basis of
1
ultraviolet, mass spectral and H-nmr evidence. Repeated 
experiments revealed a consistent metabolite pattern. A 
typical H.P.L.C. trace is given in Fig. 3«3«2i. Each product 
was identified by ultraviolet evidence, and, if sufficiently 
abundant, by mass spectral means.
M 9
ELUTION VOL An! 
« — *
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A summary of the ultraviolet data is given in Table 3.2, 
with the spectra shown, with assignments, in Fig. 3»3.2ii.
Table 3*2 Ultraviolet spectra of the 12-Methyl ketone metabolites
Fraction Xmax, nm Assignment
+BHZt-
M Microsomal
a 2 7 2 ,3 2 1 ,3 3 3 2 5 7 ,2 6 6 , 3 1 0 quasi-diaxial 1, 2 , 15-
355sh,375 Dihydrotriol
b 260,355sh 2 3 8 ,2 5 6 , 2 6 7 A-ring Metabolised
c 2 6 1 ,3 0 3 ,3 1 5 239,257,266 1,2-Dihydrodiol
327
d 268,362,37^ 246,322 3,4,15-Dihydrotriol
e 2 6 9 ,360,372sh 245,308,322 3,4,16-Dihydrotriol
f 264,358 242 Methyl,3,4-Triol
g 270,355,375sh 248,310,323 3,4-Dihydrodiol
342
h 269,300,370 250,279sh,301 Methyl, 15/l6-Diol
311,343,361
i 270,308,358 259 Methyl/15/l6-Monol
375
.238 2 6 0
266
257 HO.272 OH
3 5 5
355
375
110
.246
268
OH
3 62
322
266
3 0 3
261 315
327
OH
OH
13^
245
269
OH
HO
OH
360
242
!64
HO-HC
HO'
OH
358
248
•70
HO'
OH
355
075
323
342
279
HO H ip
269 \
‘OH250
311
i70
300
361
135
270
OH
306
358 375
Fig. 3.3.2ii
The product (M) is microsomal, and contained no radioactivity, 
when labelled compound was metabolised.
Metabolite (a) had ultraviolet spectra typical of a 
1 ,2 ,15-dihydrotriol, with the 1 ,2-dihydrodiol in a quasi- 
diaxial conformation. This is analagous to the product formed
from the 11-methyl isomer (lb), displaying the characteristic
A llmax value on borohydride reduction.
The next product to elute (b), gave an ultraviolet spectrum 
reminiscent of the synthetic 1 ,2 ,3 *^ - tetrahydro-1 1-methyl
Q
ketone. This therefore suggests complete saturation of the 
A-ring. The retention time is not consistent with that of
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a tetraol, so some conjugation has possibly occurred to 
reduce its polarity. The broadness of the peak suggested 
that it contained more than one species • On rechromatographing 
under the same conditions, the product was resolved into 
two fractions (Fig. 3*3»2iii) 1 each of which had similar 
ultraviolet spectra to the product from the initial separation.
ELUTION VOL/ml
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Fig 3.3.2iii
The compound corresponding to peak 1 c* was identified as 
the quasi-diaxial1,2 -dihydrodiol. The stereochemistry was
137
assigned on the basis of retention time and the borohydride 
reduction spectrum. In the isomeric ketone (lb), the 
1 ,2-dihydrodiol is not found in quantity, but metabolism of 
the unsubstituted compound (la) yields such a product.
The strong X max values in the ultraviolet spectrum at 3^2- 
37^nm., enable fraction (d) to be identified as the 3 »^i15- 
dihydrotriol, whilst (e) is assigned the structure 3 i^il6- 
dihydrotriol. The high level of 15 or 16 oxidation observed 
in this compound is reflected in the quantity of these triols 
formed. Methyl metabolism in this isomer is minimal, 
providing the major difference between it and the 11-methyl 
isomer (lb). The methyl hydroxylated triol (f) elutes later 
than the 15 and l6 hydroxylated triols, presumably due to 
intramolecular hydrogen bonding between the hydroxyl group 
and the ketone function. In any case it is only formed in 
small amounts.
The 3 ,4-.dihydrodiol (g) has been fully characterised previously, 
and binds to the greatest extent to DNA in vitro of all the 
metabolites tested. (See chapter 4.)
The other diol present (h), is present in a lower amount 
than in the llr-methyl ketone (lb), and is assigned the structure 
of methyl 15 or 16-diol. In all probability it consists of 
a mixture of them both. Similarly the major metabolite 
denoted a monol (i) is not readily identified, although 
coelution may be occurring. As 15-hydroxylated products
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are more abundant than the corresponding l6-hydroxylated isomers, 
it is likely that the 15-monol predominates.
Mass Spectra of the major metabolites (a,d,e,i) are presented
in Table 3«3» The data for the 3i^-dihydrodiol (g) has
4been reported elsewhere.
Table 3»3 Mass Spectral Data of the 12-Methyl ketone metabolites
*
Metabolite Molecular Formula Ions with Assignments
a Cl8H l6°4 2 9 6(6,M+) ,278(l4,M-H2o)
2 6 2(1 1),2 6 0(9 ,M-H20 ),1 7 0(5 0 )
6 0 (1 0 0)
d ci8h i6°4 2 2 3(8 ),1 7 0(6 7 ),1 5 5(1 0 0),127(79)
e ci8h i6°4 278(13,m-H2o),2 6 3(1 0),2 6 2(1 8)
2 6 0(2 0 ,M-2H20)
2 3 2(M-2 (H 0)-C0),2 3 1(1 0) 
200(10),170(65) ,155(100) ,127(58) 
i Cl8H l4 ° 2 2 6 3(2 3 ),2 6 2(1 0 0,M+)
245(11,M-0H),244(13,m-h2o)
2 3 3(1 4),2 1 9(2 1 ),2 1 8(1 4),217(45) 
2 1 6(2 3 ,m -c o -h 2o ),2 1 5(2 8 )
213(11),205(11),203(23),202(35) 
Note * Ions other than the molecular ions of m/e over 
200 and abundance of 10% compared with the base peak are 
listed. Those ions between 100 and 200 m/e are listed when 
the relative abundance is greater than 50%.
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Using such small quantities of compounds, the information 
obtained is inevitably limited. The molecular ions, and 
their dehydration products, are of main interest in
these studies.
It can be readily seen that for the monol (i), the parent
and base peak are one and the same. This compares well with
11the similar 11-methyl,15-monol. In the case of the 
dihydrotriol (e), (M-H^O) is found (either by thermal elimin­
ation in the ion chamber, or during ionisation), but the 
base peak is of mass 155m/e, with a prominent ion at 170m/e. 
Several ions are assumed to derive from the phenol formed 
by loss of water, including that of the base peak. This
» I 9 9
could be derived from rings A and B of the original compound, 
Fig. 3•3-2iii
CH
HOHOHO
Fig. 3.3.2iii
Of the peak at 170m/e, the most probable ion is that of
/C^^H^q O+_/. Overall the initial fragmentation pattern is very
11
similar to that of the isomeric 11-methyl3 *^i16- dihydrotriol•
The metabolite (d), identified as the 3 i^i15“ dihydrotriol 
shows a remarkable mass spectrum, with only an ion of m/e 
223(8) having a mass greater then 200. However the base 
peak is at m/e 155 with a prominent ion at m/e 170, resembling 
those of the triol (e). This is to be expected from the 
assignment previously given to these two ions. That ion 
having m/e223, corresponding to a mass loss of 55 Daltons 
from the original molecule, is very prominent and is possibly
equivalent to a loss of C^H^0+ /, which would be derived
from ring D'. Only in the two triols are the ions of m/e 155 
and 177 found.
With the 1,2,15-dihydrotriol (a), the parent ion is found 
as the molecular ion (m/e296). The ion corresponding to 
( M - H ^ O )  is also found, which is typical of the dihydrodiols.
A large peak is found equivalent to an ion of m/e 170, but 
none is found at m/e 1551 which would be consistent with the 
derivation of these ions. The base ion is found as m/e 60, 
probably being a 'D’ ring derivative with the formula /_ C^H^O^^/-
Thus it may be seen that the mass spectral data supports the 
ultraviolet and H.P.L.C. evidence of the metabolites of 
this compounds. A summary is shown in Fig. 3»3»2iv.
lkl
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Fig. 3.3«2iv
1^2
3.3. 3 The In Vitro Metabolism of 15,•l6-Dihydro-11,12-Dimethyl- 
cyclopenta-/ a /-phenanthren - 17-one
The metabolism of this carcinogenic compound has not 
previously been studied. A wide range of metabolites were 
formed, and assignments were made as before on the ultra­
violet and H.P.L.C. data. The H.P.L.C. trace is shown in 
Fig. 3.3.3i, and the ultraviolet spectra, shown in Fig. 
3.3.3ii, are summarised in Table 3*^
JL X
50 100 X200 250 300 350
Elution Volume /m l.
Fig. 3.3-3i
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Table 3»4 Ultraviolet spectra of the 11,12-Dimethyl ketone 
metabolites
Fraction Xmax , nm 
4-BH^
Assignment
M Microsomal
a 2 7 3 ,3 2 3 ,3 3 6 2 6 1 ,2 7 0 , 3 2 8 quasi-Diaxial
3 6 6,386 1,2,15-Dihydrotriol
b 275,32 3sh 252,332,3^9 3,4,15-Dihydrotriol
338sh , 373
c 2 7 6 ,320sh 254,320,33^ 3,4,16-Dihydrotriol
338sh , 372 350
d 2 7 2 ,3 0 5 ,3 6 7 258,283,293 Phenanthrene Diol
384 305 -
e 2 7 0 ,2 9 0sh 259,283,296 Phenanthrene Diol
306sh,3 6 2 ,3 7 9 309
f 273,303sh, 365 2 6 0 ,303sh Phenanthrene Diol
383
g 275,321sh, 336 256,274,3 2 1 3,4-Dihydrodiol
370,381 337
h 2 6 9 ,2 9 0sh,304 15-Monol
367,384
i 268 ,2 9 1sh, 303 2 5 9 ,2 9 6 , 3 3 2 l6-Monol
363,383 356
lkk
,320
OH
,338
275
372
332
349
270
HO
261 HO.
OH
328
366 386
334
320 * \  
1
OH /
H 0 ‘
OH 350
254 276
372
272
258,
PHENANTHRENE DIOL
305
•67 3Q4283
293
!59
270
PHENAMTHRENE DIOL
PHENANTHRENE DIOL
273 \
303
383
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303
275
HO'
256 OH
.321
336
\  274
370 381
321
269
290
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384367
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Fig 3.3.3ii
As with the previous compounds, similar metabolites tended 
to elute with comparable retention times, enabling the whole 
range of products to be classified into certain groups.
With this compound, the initial eluting fractions (a-c) , 
after the microsomal (M) peak, can be denoted triols of one 
form or another. The typical borohydride reduction spectrum 
of (a) identifies the quasi-diaxial 1 ,2 ,15-dihydrotriol, in 
a similar manner to the other compounds in this series. The 
relatively small quantity of this particular product has no 
obvious explanation, as 1 ,2-epoxidation readily occurs when 
the compound binds to DNA in vitro (chapter 4).
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Products (b) and (c), also triols, are the 3*4,15 and 3*^*l6-
dihydrotriols respectively. Additionally either of the
friethyl hydroxylated 3 * 4-tlihydrodiols may have coeluted with
them, although that product eluting immediately before (b)
may be one of these. No spectral evidence is available on
this minor metabolite. These two major metabolites (b and c)
are exactly analogous to those from the more carcinogenic
11-methyl ketone, where the 3 * 4,16-dihydrotriol is known to
produce tumours on mice skin, whereas the 3 * 4,15-dihydrotriol
10is much less active. Both of the 11-methyl dihydrotriols 
bind extensively to DNA in vitro,^  and it is likely that 
these two compounds would behave in a similar manner.
The next group of compounds to elute from the column (d-g)
contain various diols, of which (g) has typical spectral
characteristics of a 3 * 4-dihydrodiol. This might be expected
to bind most effectively to DNA following 1,2-epoxidation,
of all the metabolites produced, if the mechanism of binding
is directly analogous to the 11-methyl-ketone (lb). It is
significant that a good proportion of the starting material
is converted to this particular product, as the compound (Id)
shows high levels of DNA binding (chapter 4) and is also 
12carcinogenic•
The other four compounds within this group have ultraviolet 
spectra consistent with intact phenanthrene nuclei. There 
are a potential six 11 phenanthrene diols", where no interruption 
of the aromatic system has occurred, which are illustrated in
lkS
Fig. 3»3-3iii- No assignment can be made on available 
evidence, suffice to say that it is likely that 11-methyl 
hydroxylation predominates over 12-methyl hydroxylation, as 
in the metabolism of the 12-methyl compound (Ic), minimal 
quantities of methyl hydroxylated products are found. Some 
of these peaks may be mixtures of the various diols, and 
the presence of a shoulder on the main peak of (g) suggests 
that another product may be present.
Fig. 3.3.3iii
Ik9
Peak (h) dominates the next group of metabolites, which 
consist of various monols. This major peak, the most abundant 
of any metabolite, possibly contains both 15 and 16-hydroxy 
isomers. The presence of other peaks in this region of the 
trace may be rationalised, as there are four possible monols.
No spectral data is available on these minor products.
The general similarity of the metabolism of this compound to 
the 1 1-methyl-ketone (lb), indicates -that the dimethylated 
compound is able to produce the analogous proximate carcinogen, 
thus suggesting a rationalisation of its tumourogenic capacity, 
A summary of the metabolism is given in Fig, 3»3»3iv.
150
OHHO PHENANTHRENE 
DIOLS +
OHOH
OH
.OH
HO HO4HQ'
OH HO HO
Fig. 3.3.3iv
151
3 . 3 »^  The In Vitro Metabolism of 13»l6-Pihydrocyclopenta- 
/ a 7 -phenanthren-17-one
As the parent compound in this series (la), the metabolic
pathway and products are of great importance.' Although not
carcinogenic in itself, it is mutagenic when subject to the
5
bacterial Ames test. Previous work has established the 
formation of a 3 i4-trans-dihydrodiol, amongst its metabolites, 
a species which has been shown to lead a syn-3 ,4-trans- 
dihydrodiol-1,2-oxide (VI). This does not bind very well to 
DNA either in vitro or in vivo.
A typical H.P.L.C. trace is presented (Fig. 3-3*^i)i together 
with the ultraviolet spectra of the products (Fig. 3*3*^ii) 
and a summary of them (Table 3-5)• The absence of a methyl 
group greatly simplifies the task of assigning structures to 
metabolites.
6
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Table 3«5 Ultraviolet spectra of the Unsubstituted ketone 
metabolites
Fraction .max, nm
+b h4-
Assignment
M
a
h
2 6 6 ,3 2 0 ,3 3 2  
366
2 6 6 ,2 7 2 ,3 1 6  
3 2 8,346sh, 365 
267,317,327 
345sh , 365
2 6 8 ,320sh 
350sh , 366
2 6 9 ,350sh , 368 
2 7 0 ,2 8 3sh , 2 9 8
351,370
2 6 8 ,2 8 0sh ,297
352.369 
267,285,299
352.370
255,264,310 
3^ 7
257,265
243,3 0 0 ,3 0 9
3 2 1,341
250.257.278
2 8 7 . 2 9 8
248.256.278
2 8 1 . 2 9 8  
2 5 0sh,257,279
288.299
Micros omal 
quasi-diaxial 
1,2,15-Dihydrotriol 
1,2-Dihydrodiol
243,264,320 3,4,15-Dihydrotriol
2 4 3 ,3 0 8 ,3 1 8 3,4,16-Dihydrotriol
3,4-Dihydrodiol
15,16-Diol
15-Monol
l6-Monol
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328265 316
257
346
365
264
2551
266
OH 366
332
347
310
243
327
267
345
365
264
320
l$k
270
OH
OH
283
298
278
\  28'
351
370
321
3 0 9 /
243 300.
269
341
HO'
350
368
2S7
.OH
285
299
V 279' y \ 352
370
256 268
248.
280 352
369
297
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There is no reason to suggest that peak (a) corresponds to
anything other than the quasi-diaxial 1 ,2 ,15-dihydrotriol.
Little, if any of the corresponding 1,2,16-dihydrotriol is
11found amongst the metabolites of this series. The 1,2-dihydro- 
diol moiety is readily identified from the reduced spectrum, 
and the quasi-diaxial conformation is dominant, despite the 
absence of a methyl group in the bay region.
The peak denoted (b) again displays 1,2-dihydrodiol character­
istics in its reduced spectrum, and may be thus identified.
The absence of strong bands in the ultraviolet spectrum at 
322-366nm., which are associated with 15-hydroxylation, suggests 
that this compound is not the quasi-diequatorial 1 ,2 ,15- 
dihydrotriol, such as is found amongst the 1-methyl-ketone 
(VII) metabolites. The 1,2-dihydrodiol is prominent in both 
this compound, and the 12-methyl ketone (Ic), whereas the 
presence of an 11-methyl group presumably does not favour the 
formation of this compound. The production of it is therefore 
an additional detoxification mechanism.
Compounds (c) and (d) are readily identified as the 3i^i15- 
dihydrotriol and its 3?^il6-isomer respectively. The former 
is identified by the stronger Xmax values at 330-360nm. Here 
the 15-hydroxylated isomer (c) is present in much greater 
quantities than (d). Both of them might be expected to 
bind to DNA via epoxidation to the 1,2-oxide. However in vivo 
binding is minimal, thus explaining the lack of tumourogenic 
activity•
In addition to (c) and (d), the trans- 3 i dihydrodiol is
present in considerable amounts. It has previously been
4
fully identified.
The retention time of a diol, retaining an intact phenanthrene 
nucleus, enables an unequivocal assignment of the 1 5,l6-diol 
to be given to metabolite (f). A 1 5 ,15- or l6 ,l6-diol would 
spontaneously eliminate water to form a ketone. The increased 
retention time of this compound is probably due to hydrogen 
bonding between the hydroxyl groups and the ketone function 
in a similar manner to that of the 1-methyl compound (XI).
The final pair of metabolites contain the monols (g and h).
With such a simple molecule, they can only be the 15 and l6- 
monols. The predominance of the 15-hydroxyl species (g) should 
be noted. The peak preceeding it is unidentified.
The overall study of this compound has meant an easier 
identification of all the major metabolites by this method.
The positive identification of species such as the 1 5 ,l6-diol 
(f) provide important precedents for the study of more 
complex members of this series of compounds. A summary of 
the metabolism is given in Fig. 3»3»^iii*
Fig3.3.4iii
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3«3«5 Comparison of the Metabolism of a series of 15,16- 
Dihydrocyclopenta-/ a 7 -phenanthren-17-ones
The in vitro metabolism of the four ketones (Ia-d) was
studied in parallel under identical conditions. The compounds
(ljjmol) of known radioactivity were used, and a proportion
of each fraction assayed for tritium content. The total
in the organic phase was found, and for each metabolite the
percentage of the total recovered was quoted. That designated
aqueous metabolites would contain tritium exchanged into
water, as well as any water soluble molecules. Each metabolism
was performed in duplicate with the exception of the 11-
methyl ketone (lb). The metabolism of the latter has been
9 11thoroughly investigated. *
A diagram illustrating the H.P.L.C. traces of all four 
compounds is shown in Fig. 3»3»5ii and the results of the 
comparative experiments summarised in Table 3*8.
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Unsubs
11-Me
4TI
12-Me
11,12-Dime
Fig 3 .3 .5i
Table 3*6 Comparison of the four ketones (Ia-d)
Metabolite Unsubstituted 11-Methyl 12-Methyl 11,12-Dimethyl
(la) (lb) (Ic) (Id)
1.2.15- 1 1 .2 (a) 8 .0 (a) 5 .2 (a) 0 .9 (a)
Dihydrotriol
3.4.15- 9 .2 (c) 5 .7 (b) 1 2.1(d) 6 .3 (b)
Dihydrotriol
3.4.16- 4.2(d) 4.0(c) 6 .0 (e) 5 .3(c)
Dihydrotriol
3 ,4- 1 1.6 (e) 9 .2 (e) 7 .7 (g) 9 .2 (g)
Dihydrodiol
Aromatic 4.1(f) 8.0(d - f)
Diols . ,
15-Monol 4.3(g) 10.8(f)
1.7(i) 11.1(h,i)
16-Monol 2.9(h) 4.4(g)
Unchanged 23*8(i) 24.2(h) 27*6(j) 25*l(j)
Other 24.4 26.8 35-3 3 5 - 2
Compounds
Note
i All figures are percentages of the total recovered in 
the organic phase.
ii Numbers following figures refer to the metabolic numbers 
from previous discussion.
In all four cases, the amount of unchanged compound was about 
25%, thus all of them exhibited a similar extent of reaction. 
Minor metabolites accounted for a further 24.4-35*3%, with
the greatest amount being found amongst the two 12-methylated 
ketones. Although metabolism at the 12-methyl group did not 
produce many major metabolites, the large number of minor 
products suggests that they were formed, though in small 
quantities.
The 1,2,15-dihydrotriols vary in their relative percentages 
by a factor of over ten, with the most being found in the 
least hindered unsubstituted ketone (la). The methyl groups 
would appear to have an important role here, as the combined 
effect of two reduces the amount of this product even more.
It is possible that the substituent groups prevent good binding 
into the active site of the relevant enzyme. Alternatively 
complex kinetic reasons, resultant from many reactions proceeding 
at once, could be the cause. The net result must always be 
to increased detoxification the more of this metabolite is 
formed.
The 11-methyl substituted compounds (lb and d) exhibit a 
significantly lower percentage of the 3 ,4,15-dihydrotriol 
amongst their metabolites than the non-carcinogenic pair of 
compounds (la and c). A comparison of the 15-hydroxylated 
products is worthy of attention, as the 11-methyl group 
apparently inhibits production of the triol from the monols, 
which are more predominant in such substituted compounds.
Metabolism at position 16 is generally rarer, and the 3i4- 
dihydrodiol derivatives are only present in small quantities.
The oxidation of the l6-monol is probably independent of 
methyl substitution pattern.
The most important metabolities are the 3,4-dihydrodiols 
owing to their ability to act as proximate carcinogens.
With the exception of the 11,12-dimethyl ketone (Id), all 
have been fully characterised and the nature of the stereo­
chemistry of their diolepoxides determined. DNA binding 
studies in vitro and in vivo, showed a series of adducts 
were formed, of which tie major one was the result of 
nucleophilic attack of a deoxy-guanosine residue with their 
diolepoxides. In assessing carcinogenicity in a series 
such as this, knowledge of the relative proportions of 
certain critical metabolites will be fundamental to discovering 
if tumourogenicity is directly related to the quantity of 
proximate carcinogen formed. The absence of a 3 i4-dihydrodiol 
amongst the metabolites (e.g. in the 1-methyl-ketone (VII)) 
would immediately mitigate against such biological activity.
The 11-methyl ketone (lb) has also been examined in both
skin and liver, producing similar DNA-adducts, thus justifying the
18
use of a rat liver microsomal system in the current study.
The quantity of the diols was fairly consistent, with minimal 
differences between them. The basic precept may then be 
accepted, that, under the same conditions of metabolism, the
3,4-dihydrodiol is produced in similar quantities. The mere 
amount of this metabolite produced is not likely, therefore, 
to govern the carcinogenicity of these four compounds.
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The other diols, retaining their phenanthrene nucleus,
metabolites
are presumably pres entasj^ of all four compounds, but only in 
two (la and d) have they been separately identified.
The amount of monols varies, with the 12-methyl compound 
producing only small quantities. There was no satisfactory 
separation between the two D ring monols in the 12-rtiethylated 
compounds. It is probable that in the 12-methyl compound the 15- 
monol was effectively transformed to the 1 ,2 ,15-dihydrotriol •
The small proportion present in the products of the unsub­
stituted ketone is possibly due to the lack of coeluting 
methyl hydroxylated species.
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4.1 Introduction
It has been shown that the carcinogen, 15,l6-dihydro-11-methyl-
cyclopenta-/ a_7-phenanthren-17-one (I), on biological
activation, binds to DNA in vitro, as does the non-carcinogenic
\
parent ketone (II). Despite the difference in carcinogenicity,
2 3both compounds are mutagenic in the Ames test. Additionally,
the 12-fnethyl (III) and 11,12-dimethyl (IV) derivatives
exhibit different biological activities , the former being
4inactive in both animal and bacterial tests, whilst the
opposite is true of the latter. The dimethylated ketone (IV)
carcinogenic c
is^to a lesser extent-than the 11-methyl ketone (I).
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A detailed study of the way these compounds bind to DNA 
in vivo has been performed to identify the adducts formed 
and to assess the relative amounts of binding. Such work 
would help to determine if a simple correlation between the 
quantity of a specific adduct and carcinogenic activity exists.
Different adducts are identified by initial in vitro studies 
using the original compounds and their derived metabolites. 
This has already been achieved for the 11-methyl compound (1).^ 
Additionally the comparison of in vitro and in vivo adduct 
patterns will help in assessing the relevance of such 
in vitro methods. The 11-methyl compound gave rise predom­
inantly to one adduct, in vitro, corresponding to that derived
6 7from its anti-314-trans-dihydrodiol-1,2-oxide (V) . 1 
The adduct (VI) is formed by nucleophilic attack of the 
exocyclic amine function of guanosine residues in DNA on 
the epoxide at position 1. Similar studies have therefore 
been performed on the 12-methyl compound.
o
HO'
HO
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It is obviously important to positively identify the nucleoside
14of the major 12-methyl ketone adduct. To do this, C labelled
DNA (dG and dA) was prepared from E, Coli bacteria using a
8 9 10 11technique similar to that used by Marmur. 1 By
coeluting tritiated adducts obtained from the in vivo experiments, 
with carbon-14 labelled adducts derived from in vitro binding 
of the unlabelled compound to the prepared bacterial DNA, 
will enable identification to be made. Previously, similar 
work had been performed on the 11-methyl ketone (I).
Both the 11 and 12-methyl compounds (I and III) form identical
12adducts, with the stereochemistry as shown in (VI).
Preliminary experiments have indicated a large difference in
1 3the level of binding of the two compounds, whilst skin
painting experiments on mice, by continuous application,
have revealed the lack of tumourogenic activity in the 12- 
4methyl isomer. Work is currently in progress to assess the 
biological activity of it by initiation and promotion methods.
In a similar manner, the 11-methyl ketone (I) is being tested 
over a range of doses (50-1000nM) per mouse.
The aim of the overall investigation was to obtain the 
binding ratio of the 12-methyl ketone (ill) at a dose of 
lOOOnmoles per mouse, and then to determine what dose of the 
11-methyl ketone (I) will give the same binding ratio. Such 
knowledge will indicate whether the difference in biological 
activity is merely dependent on the amount of adduct present, 
when considered in conjunction with the tumourogenicity data
at the different doses. The binding ratio was therefore 
determined at the same concentrations of applied compound, 
as used in the animal tests. If the 11-methyl ketone (I) 
produced tumours at a lower concentration of adduct than 
the 12-methyl isomer (III), then a simple relationship between 
binding ratio and carcinogenicity could be ruled out.
The repair of DNA, modified in vivo by the 11-methyl compound 
(I), has previously been studied by calculating the rate
14at which the adducts are excised. It was shown that 
all the major adducts were lost at the same rate as that 
of DNA turnover in the skin. A similar study is necessary 
on the 12-methyl isomer (III), to see if the adducts are 
lost from DNA at a different rate, thus possibly implicating 
repair mechanisms as significant in the non-tumourogenicity 
of this compound. Mice were therefore treated with the 
compound at a fixed dose (lOOOnM/mouse) and sacrificed at 
various time points, over a twenty day period, to determine 
the binding ratio at each time point.
171
4.2 Experimental
4.2.1 Materials
All the compounds used were obtained from the laboratories 
of the Imperial Cancer Research Fund. They were tritiated 
as described in Chapter 1, and diluted with unlabelled compound 
to give the desired specific activity. Each was kept in dry 
benzene at 0°C until required.
4.2.2 Animals
All the animals used for binding experiments were male, Theilers 
Original mice. They were obtained from an inbred strain at 
the Imperial Cancer Research Fund, and were aged 15 weeks when 
used (in random groups of ten). The day before use, their 
backs were shaved, and on the following day the compound was 
added as a solution in acetone (50yul) from a syringe delivering 
lO^ il in a single drop.
The mice were killed by cervical dislocation, and the shaved 
area of skin removed within a few minutes of death. The 
skin was cut into small fragments prior to freezing in liquid 
nitrogen. The pieces were kept wrapped in aluminium foil at 
-70°C until needed, under which conditions they could be kept 
for extended periods of time.
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4.3»3 Extraction of DNA from Mouse Skin
The frozen skins (equivalent to one group of ten mice) were 
homogenised using a Polytron P-20 (Northern Media Supplies,
N. Humberside, U.K.) in a solution of p-aminosalicyclic acid 
and sodium chloride (100ml, 5% and 1% respectively). The 
homogenate was extracted with equal volumes of a phenolic 
preparation:- phenol (500g), redistilled m-cresol (70g),
8-hydroxyquinoline (0.5g) and water (55^1). The resulting
p
mixture was spun in a Sorvall centrifuge using 30ml Corex 
tubes at 10,000rpm for 10-15 minutes. This procedure was 
repeated twice more using equal volumes of the phenol mixture 
at each stage. The aqueous layer was transferred to a 
dialysis sac and dialysed against running tap water overnight. 
Further dialysis against distilled water was performed for 
two hours, after which the volume was reduced to ten mis.
To this solution, tris buffer (pH 8.0) was used to make the 
concentration 0.01M with respect to the buffer. Proteinase K 
(Sigma, London, U.K.) was added at a concentration of O.lmg/ 
ml and incubated at 37°C for two hours to remove any remaining 
protein. On completion of the reaction, the enzyme was 
deactivated by heating at 70-80°C for two minutes.
Sodium acetate solution was added to make an overall concentration 
of 4%, to which RNaseA (Sigma, London, U.K., 2mg/ml) in sodium 
chloride (0.15m) was added. The enzyme had previously been 
heated at 70°C for ten minutes to destroy the activity of any 
DNase present.
The solution of the RNase and products was incubated at 
37°C for two hours, whereupon the contents of the flask were 
extracted with the phenol mixture, as before, dialysed 
against running tap water overnight, and then against distilled 
water for four hours. An estimate of the quantity of purified 
DNA present was made using an ultraviolet optical density 
reading at A - 260nm.
4.2.4 Hydrolysis of DNA
The solution of DNA was made such that the concentration was 
lmg/ml and lOmmolar with respect to both tris buffer (pH7«2) 
and magnesium chloride. DNase (Bovine Pancreas - Sigma, London, 
U.K.) at 260 units/mg DNA was added and incubated at 37°C for
at least 2-3 hours.
After hydrolysis was complete, an equal volume of tris buffer 
(0.1M, pH9*0) was added, together with alkaline phosphatase 
(Sigma, London, U.K., 25^il) and snake venom phosphodiesterase 
(Sigma, London, U.K., 2mg) which were left at 37°C overnight. 
The volume was taken down to about 2ml, under reduced pressure, 
and sufficient methanol (A.R.) was added to make the solution 
20%. This was then spun in a Sorvall centrifuge (4,000rpm,
5 mins) to precipitate the enzymes, after which the supernatent 
was added to a Sephedex LH-20 column. Elution was performed
at a rate of 0.5ml per minute for one hundred samples of
ten ml, using a gradient of 20% methanol/water to 100% methanol. 
Continuous ultraviolet monitoring of the eluant CA =254nm) was
performed. From each sample a 0.5ml aliquot was taken and 
added to liquid scintillator fluid (Aquasol-New England 
Nuclear, U.K., 4ml). In each of these fractions the radio­
activity was determined, and those shown to contain DNA-ketone 
adducts were pooled and reduced in volume.
The adducts were separated using high performance liquid 
chromatography (H.P.L.C., Waters Associates) on a reverse- 
phase Whatman Partisil 10 O.D.S. column (25x4.6mm), using a 
linear gradient of 10% methanol/water increasing by 0.2 ml 
of methanol per minute, at a flow rate of 1.0ml per minute. 
Each 1.0ml fraction was collected, and scintillation fluid 
added (4.0ml). The radioactivity was determined and plotted 
against retention time (mins).
144.2.5 Preparation of C-DNA
E. Coli bacteria were grown in a medium containing either
/_ adenine or /_ guanine . Isolation procedures
S iowere based upon the methods of Marmur and Kirby. The 
paste resulting from such growth, was taken and stored at 
-10°C.
For 10ml of paste p-.aminosalicylate solution (6%, lOm}.) , was 
added and lysed at room temperature by the addition of sodium 
dodecylsulphate (10%, 1ml), and then stirred for 2-3 hours.
The protein was removed by shaking the viscous lysate with the 
phenolic solution (8ml) of the same composition as in 4.2.3*
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From the aqueous phase, the DNA was precipitated with the 
addition of ethoxyethanol (1.5 vol, redistilled).
The crude DNA was wound onto a glass rod, washed with 
ethoxyethanol (90ml), ethanol, and finally diethyl ether, 
before being allowed to air dry. The dried product was 
dissolved in water (90ml) and stirred with a buffer solution, 
(sodium chloride (1.5M): sodium Gitrate (0.15M), pH7«2,
l4.4ml). Ribonuclease A (Sigma, London, U.K., 6mg) was 
dissolved in water (2ml), heated to 80~°C for ten minutes (to 
destroy the activity of any DNase present), cooled, added to 
the DNA solution at 37°C., and left for one hour.
oc-Amylase Type 1A from the ho& pancreas (Sigma, London, U.K.,
100|il=units) , was mixed with the DNA solution and stirred
overnight at 4°C. Protease K Type XI, fungal (Sigma,
London, U.K., 2mg) was added to the mixture and maintained at
20°C for three hours• The DNA was extracted
and precipitated as previously described.
The product was dried over P Q0_ in a vacuum desiccator for
2 5
one hour•
Initial extraction gave a higher yield than expected of 
DNA, but the ultraviolet spectrum showed it to be impure.
The procedure was therefore repeated, using dialysis methods 
to remove the hydrolysed proteins. The details of the DNA 
finally prepared are outlined in Table 4.1
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Table 4.1 Details of the C-DNA
DNA Prepared Mass of Dried Product (mg) Radioactivity (dpm)
/ l/lC-dA_7 
/” lZtC-dG 7 8
7 12.8x10
8.1xl05
6
4.2.6 In Vitro Binding Conditions
A pellet of microsomal enzymes was prepared from the rat 
liver homogenate as described in Chapter 3» of liver
were necessary to provide sufficient enzymes for 5mS of DNA. 
Normally calf thymus DNA (Sigma, London, U.K.) was used, 
although conditions were not altered when the bacterial DNA 
was utilized. The DNA (5mg) was dissolved in water (1.0ml) 
and NADPH (l2.5mg) was added. Agar (0.18%, 1.0ml) was used 
to help stabilise the enzymes. The compound (250yug), as a 
solution in dimethyl sulphoxide (A.R., lOOjil) , was added 
immediately before the enzyme solution. The microsomal 
pellet was suspended in buffer (0.1M tris-HCl,pH7«2), to 
make a total volume of five mis. The final solution was 
shaken at 37°C, open to the atmosphere, for 2-3 hours.
The reaction was halted by the addition of chloroform 
saturated tris-phenol (0.1M, pH7«2, 3xvol), shaken, and spun 
at 8000rpm for twenty minutes on a Sorvall centrifuge using 
Corex 30ml tubes. The supernatant was removed, combined with 
two volumes of ethanol and left at -20°C for 16 hours.
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On standing, the mixture was spun as before at 0°C. The 
resulting pellet was washed with ethanol and diethyl ether, 
before being left to dry at room temperature. The crude 
DNA was taken up in tris buffer solution (pH7-2, lCmM, magnesium 
chloride, lOmM, 2.0ml) and an optical density measurement 
made (A=260nm) to determine the quantity of nucleic acids 
present.
Hydrolysis of the DNA and separation of the products was 
achieved in the same manner as described in 4.2.4.
4.3 Results and Discussion
4.3.1 The In Vitro Binding of the 11* and 12-Methyl ketones, 
and their derived metabolites, to DNA
Initial experiments were concerned with the direct comparison 
of the abilities of the 11-rrtethyl and 12-methyl (I and III) 
ketones to bind to calf thymus DNA. A summary of the results 
is given in Table 4.2, where the quantity of radioactivity in 
the different adduct peaks is given.
Table 4.2 In Vitro Binding of the 11-and 12-Methyl ketones to DNA
11-Methyl ketone (I) 12-Methyl ketone (III
Total Radioactivity 29.5 12.9
Used (mCi)
Total Radioactivity 129.2 12.2
Recovered - exLH20(pCi) (0.4)
Radioactivity in Peak 31•5
(0.1)
2.2
1 A* (juCi)
{% of Eluted activity)
(24.4) (18.0)
Radioactivity in Peak 66.0 3.0
B (^ uCi )
(%of Eluted Activity)
(51.0) (24.5)
Radioactivity in Peak 0.8
C (yuCi)
(% of Eluted Activity)
(6.5)
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Although the quantity of compound used was identical, the 
specific activity differed, and so the •corrected* activity 
for each peak is given in Table 4.3, and illustrated in 
Fig. 4.3.li, where the radioactivity from the LH20 column, 
is plotted against time.
Table 4.3 Corrected data from the in vitro metabolisms
Peak A Peak B Peak C
11-Methyl ketone 31-5 6 6 . 0
(jjCi) {% of total) (24.5) (51.0)
12-Methyl ketone 5.0 6.9 1 .8
(uCi) (% of total)
>38
(1 8.0 )
1
(24.5) (6.5)
Fig. 4.3*li Initial Separation of 11 and 12-Methyl adducts
i8o
The four deoxynucleosides, eluting before the main carcinogen- 
nucleoside adducts, are shown on the ultraviolet trace. The 
adduct fractions are denoted 'A1 , 'B1 , and 'C1 in order of
elution. Peak *C* is only found during in vitro studies, 
and in the case of the 11-methyl ketone was only observed 
when the DNA was in direct contact with the microsomal 
mixture.^
Abbott and Coombs have discussed the nature of the so called 
'X-peak* , which they assign to non-covalently bound carcinogen, 
coeluting with deoxythymidine and deoxycytidine• The early 
elution seems to be associated with an interaction with the 
tris buffer used in the DNA hydrolysis.
The activation that is required for the binding of the 12-
methyl compound (III) is exactly analogous to that of the
6 7 1 *511-methyl isomer (I). ’ 1 This is via the anti-3 i trans-
dihydrodid-1,2-oxide (V), which then reacts with DNA to 
give the major deoxyguanosine adduct (VI).
Due to the reverse-phase nature of the column, the most polar 
products will be eluted first. Because of this, those adducts 
in peaks A and B may be said to be those derived from triols 
and diols respectively, where further epoxidation has 
occurred to yield the ultimate carcinogen. Peak C may correspond 
to carcinogen bound to other bases, of which deoxyadenosine 
is the most likely.
l8l
Initial analysis shows that the 12-methyl ketone is bound 
far less readily than the ll-m3thyl isomer, where only 0.09% 
of the total used is incorporated into the DNA, compared 
with 0,k% of the latter. Although the percentage of recovered 
compounds found in the 'A1 peak (equivalent to the triol- 
epoxide adducts), is similar, the molar quantities are very 
different. This is even more marked in the 'B1 peak (equivalent 
to the diolepoxide adducts). The overall ratio of the 11- 
methyl: 12-methyl binding is 7 • 1:1 >whilst for the two major
peaks * A* and'B J the ratios are 6.3:1and 9*6:1. Some rational­
isation of these results may be made when they are taken in 
conjunction with the evidence of the adduct patterns following 
H.P.L.C. separation.
The 11-methyl compound gave a simple pattern of adducts after 
such treatment, with a major in vitro adduct (VI) corresponding 
to that derived from the 3 » dihydrodiol-1,2-oxide. The 
only other major adduct is that derived from the 16- hydro- 
xylated diolepoxide.
The 12-methyl compound adducts, after H.P.L.C. separation, 
are seen to have a more complex pattern, Fig. k •lli.i. • Although 
only two major adducts are present, there are a much larger number 
of minor products, suggesting a less specific binding 
requirement.
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Fig. 4.3*2ii in vitro 12-Methyl adducts ex-H.P.L.C.
Identification of the adducts from the 12-tfnethyl ketone, 
was achieved by binding metabolites of known structure to calf 
thymus DNA, and inspecting both the initial separation (exLH20) 
and the more refined separation (exH.P.L.C.) of the adducts.
The basis of the following conclusions is largely on the 
evidence obtained from the firstseparation, as the conditions 
of the H.P.L.C. were not always consistent. The separations 
from the LH20 are displayed in Fig. k .3.liii-vii• The 
metabolites studied were (VII-XI).
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As expected, the 1,2, 15-‘-dihydrotriol (VII) gave no significant 
binding, as the 1,2-oxide, necessary for reaction with DNA,
7
has already been opened to give the 1,2-dihydrodiol system.
This is analogous to the reaction of the 11-methyl ketone
1,2,15-dihydrotriol with DNA.^
Of the other metabolites, almost all gave greater quantities 
of the 'A' peaks rather than the ' B* peaks. As any metabolite 
already containing a hydroxyl group will be further metabolised 
to the 3,4-dihydrodiol-1,2-oxide, the more polar adducts 
(peak A) are the only ones possible.
The 3 1 5 -  and 31^ »l6-dihydrotriols, both gave predominantly 
the 'A1 peak, with only small proportions of peak fB * • That 
eluting ±i peak fB ’ ma y be adduct where the compound is bound 
to a deoxyadenosine residue. H.P.L.C. charts (Fig. 4.3-lviii 
and ix) suggest that in each case only one major adduct is 
formed. The smaller quantity of these other adducts would 
appear to amount to about 5-10% of the total. The multiplicity 
of products shown in the 3»^ »15-dihydrotriol H.P.L.C. 
separation, is probably because the metabolite used contained 
some isomeric 314,methyl-dihydrotriol• Those adducts derived 
from the latter compound would have different retention times 
to the 3,4,15-dihydrotriol adducts
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Fig. 4.3«lviii Fig. 4.3.lix
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The important 3 * 4-dihydrodiol, which is the proximate
16carcinogen in the case of the 11-taethyl compound, gives 
approximately equal quantities of peaks *A* and 'B*. The H.P.L.C. 
chart (Fig. 4.3»lx) shows the main adduct to be that directly 
derived from the dihydrodiol. Other peaks of significance 
correspond to those derived from the 3*4,15 and 3 i^irrt®thyl- 
dihydrotriols, previously discussed. Further oxidation'of 
the 3 ,4-dihydrodiol is more pronounced than in the isomeric 
11-methyl ketone, thus suggesting that the 12-rriethyl-3 * 4- 
dihydrodiol has a longer lifetime. A peak eluting late is 
again found, probably being a deoxyadenosine bound product.
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The monol (XI), as expected, gives a single major adduct, 
though the broadness in the shape of the peak (Fig. 4.3«lxi) 
is probably attributable to the presence of some isomeric 
methyl hydroxylated ketone. A small peak, with a long elution 
time is again found.
A study of the relative binding of each metabolite enables a 
more confident interpretation to be given. The results are 
summarised in Table 4.4.
Table 4.4 The relative incorporation of metabolites into DNA
Metabolite Quantity in Quantity in Total Quantity
'A' peak 'B' peak (Dpm/mgDNA)
(Dpm/mgDNA) (Dpm/mgDNA)
1.2.15-Dihydrotriol
(VII)
3.4.15-Dihydrotriol
(VIII)
3.4.16-Dihydrotriol
(IX)
3,4-Dihydrodio.l
(X)
Monol (XI)
0.14x10
0 .95x 10
1.87x 10
0 .52x 10
0 .96x 10
0 .15x 10
0 .15x 10
0 .71x 10
0 .55x 10
0 .52x 10
0 .29x 10
1.10x 10
2 .58x 10
1.07x 10
1.48x10
It can thus be seen that the 3»^i16-dihydrotriol (IX) is 
bound most favourably, more so than even the 3 i4-dihydrodiol 
which in itself is bound less efficiently than the monol (XI) 
As about half of the dihydrodiol is further metabolised it 
would appear not to be very reactive, and less so than the 
isomeric 11-rrtethyl 3 i4-dihydrodiol•
The pair of triols, 3 i^>^5 and 3»^il6 provide an interesting
case, as the latter is far more favourably bound, including 
a significant quantity in the *B! peak. l6-Hydroxylation 
obviously helps binding, and presumably the presence of it 
in the monol (XI) may well be the cause of its extensive 
binding. The minor product is probably some deoxyadenosine
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bound compound, found in relatively high quantities, as is 
the case with the comparable 11-methyl compound.
On the basis of the evidence from the individual metabolites, 
assignments may be tentatively given to the adducts shown in 
Fig. 4.3*2ii. These are summarised in Table 4.5
Table 4.5 Assignment of 12-Methyl compound-DNA adducts
Adduct No. Base Compound derived from
i dG 3,4,15-Dihydrotriol
ii dG 3,4,l6-Dihydrotriol
iii dG 3,4,Methyl-Dihydrotriol
iv dG 3,4-Dihydrodiol
others unknown Any of the above
Benzo-/ a_7-pyrene (XII) has been shown to form small
17
amounts of a deoxyadenosine adduct, when studied in vivo, 
as well as modifying cytosine bases. Such a precedent is 
highly suggestive of a similar type of adduct formation, thus 
accounting for the presence of many adducts in low abundance, 
in the 12-methyl compound (III) experiments.
XII
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Overall, the 12-methyl metabolites, appear to be less reactive 
than their 11-methyl isomers, allowing a longer time for 
further metabolism, thus causing a diversity of adducts to 
be formed. The lack of tumourogenicity in the 12-methyl 
ketone may therefore be related to the detoxification of 
potentially reactive species by further metabolism.
4:. 3*2 The In Vivo Binding of a Series of Four Ketones
Mice were painted as previously described with lOOOnmoles of the 
compound 15,16-dihydrocyclopenta-/ a_7-phenanthren-17-one 
(II) and its 11-methyl (I), 12-methyl (III), and 11,12-dimethyl 
(IV) derivatives. The animals were sacrificed after 48 hours, 
the DNA isolated, hydrolysed and the adducts separated. The 
total binding is expressed as nmoles of adduct per mole of 
DNA phosphorus. The percentages of the binding in peaks 'A* 
and B, of the total binding are quoted. The 12-methyl 
compound (III) was studied twice to confirm the accuracy of 
the data collected. The results are summarised in Table 4.6
Table 4.6 The in vivo binding of ketones (I-IV)
Compound Peak 'A' Peak B* Total
(nmol/molDNA P) (nmol/molDNA P) (nmol/molDNA P)
Unsubstituted 3(16)
(II)
11-Methyl (I) 25(5)
16(84)
433(95)
19
458
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12-Methyl 64(40) 9 8 (6 0 ) 162
59.5(38) 95.5(62) 155
(III) 55(37) 93(63) 1^8
11,12-Dimethyl 308(32) 666(68) ^7k
(IV)
Substitution in the basic compound (II) dramatically increases 
the level of binding. However the metabolism of the compound 
is also related to its structure, as was discussed in Chapter 3- 
The overall level of binding is not simply related to 
tumourogenicity, as the 11-rinethyl ketone is the most carcino­
genic of the four compounds. The biological data is summarised 
in Table 4.7•
Table 4.7 Carcinogenicity and Mutagenicity of the four 
ketones (I-IV)
Compound Carcinogenicity Mutagenicity
(lball Index ) (Revertant colonies/mole)
Unsubstituted (II) <1 9*5
11-Methyl (I) 46 21.7
12-Methyl (III) <1 0.2
11,12-Dimethyl (IV) 30 1.1
a lball Index = 100 x % tumour incidence
mean latent period (in days)
Whilst the biological data appears to bear no relation to 
the level of binding of these compounds, it should be noted 
that the proportion of compound found corresponding to the
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•B * peak is most predominant in the most carcinogenic compound, 
the 11-fnethyl ketone (I), where 95% of the activity is found 
in it . The *Bf peak contains the adduct derived from the 
ultimate carcinogen, the 3 » dihydrodiol-1,2-oxide (V).
The parent compound (II), gave such low incorporations, that 
further analysis following H.P.L.C. separation was impossible.
The profiles from the LH-20 column are given in Fig. 4.3-2i-iv. 
It can be seen that some of the itritium has exchanged into 
the deoxynucleosides, readily identified by the ultraviolet 
trace. The elution for the 11-methyl ketone (Fig. 4.3»2ii) 
was at a different rate due to a pump malfunction.
The separations, for the three methylated compounds, from 
the H.P.L.C. are illustrated in Fig. 4.3«2v-vii. The 11-methyl 
adduct pattern strongly resembles that of work previously 
performed where the size of the 3 » dihydrodiol-1,2-oxide adduct 
is very large and has been previously characterised.
The 12-methyl adducts (Fig. 4.3»2vi) are formed only in small 
quantities. Repeated experiments using more mice (30) showed 
two major peaks on the H.P.L.C. patterns. In order to 
characterise the adducts, it was necessary to identify the 
bases in the DNA.
l^t ““I Zj. _
C-DNA was prepared by the incorporation of /_ C__/-adenine
 1 Zj. __
and / C__/- guanine into a strain of E. Coli bacteria. It
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would be expected that the adenine would be incorporated as
adenosine, whilst the guanine would by partially metabolised,
 \ _
and thus found as adenosine and guanosine. The / C_/-DNA 
samples could then be reacted with unlabelled compound, using 
the standard method, in vitro. Hydrolysis would yield a 
certain quantity of adduct containing the radiolabel. Coelution 
of these samples with tritiated adducts prepared in vivo 
would enable specific bases to be identified.
However, on completion of the experiment, it was seen that 
the strain of bacteria had mutated in such a way that in 
addition to guanine to adenosine metabolism,the adenine was 
also being incorporated as guanosine. Thus a scrambling of the 
label had occurred. Counting both the tritium and carbon-14, 
fractions from the H.P.L.C. did not therefore allow assignments 
to be made. The retention times suggest that the major adduct 
is a deoxyguanosine derivative, in a similar manner to the 
11-methyl equivalent. The H.P.L.C. trace from the coelution 
experiment is illustrated in Fig. t^.3iv.
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As with the in vitro experiment (Fig. 4.3-lii), a wide range 
of adducts is formed, and it would appear that the metabolism 
and subsequent binding is not particularly specific, probably 
due to the longer life time of the 3,4-dihydrodiol.
The 11,12-dimethyl compound (IV) displayed, as in vitro, a 
wide range of adducts. The 3,4-dihydrodiol adduct does, 
however dominate the pattern of products, as revealed 
following H.P.L.C. separation (Fig. 4.3* vii). The elution times 
for adducts of this compound are generally longer than the 
corresponding products from the monomethylated ketones, because 
of the reduced polarity produced by the presence of two methyl 
groups.
As the adducts derived from the 3,4-dihydrodiol-1,2-oxides are the 
most significant, the quantity of each formed was determined 
and shown in Table 4.8. The table also shows the quantities 
of the 3 i4,l6-dihydrotriol-1 ,2-oxide adducts formed.
Table 4.8 Quantities of specific adducts formed in vivo
Compound Adduct nmoles of Adduct Binding Ratio
(nmoles/m.DNA P)
11-Methyl (I) 3,4-Dihydrodiol 3.0x10"3 193
- 1,2-oxide
_Zi
11-Methyl (I) 3,4,16- 3-9x10 25
Dihydrotriol 
- 1,2-oxide
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12-Methyl 
(III)
11,12-
Dimethyl (IV) -1,2-oxide 
11,12- 3,4,16-
Dimethyl (IV) Dihydrotriol
-1,2-oxide
_4
3 .4-Dihydrodiol 2.0x10 
- 1 ,2-oxide
3.4-Dihydrodiol 5-1x10 3
1-9x 10-3
74
327
123
Once again a direct comparison may not be made between the
level of binding and the tumourogenicity of the compound. These
adducts are thought to be the most significant, as the metabolites
they are derived directly from are the most carcinogenic in
16
the 11-rtriethyl compound. A model for chemical carcinogenesis 
can not therefore be related to the quantity of a specific 
adduct within the DNA .
An interesting comparison may also be made of the in vitro 
and in vivo binding levels of the 11 and 12-rrtethyl ketones.
This are shown in Table 4.9-
Table 4.9 Comparison of in-vitro and in vivo binding
in vitro binding 
(yjmol/molDNA P) 
in vivo binding 
(nmol/molDNA P) 
in vitro/in vivo
11-Methyl (I) 12-Methyl (III) 11-Methyl/
12-Methyl
1595-2
458
3.48x 103
253-7
155
1.64x10
6 .3
3-0
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In vitro binding is favoured due to the higher concentrations, 
where in vivo the cellular environment may also make the 
genetic material inaccessible. The in vitro/in vivo ratios 
suggest that the 11-fnethyl is more reactive, where concentration 
factors are not a limiting factor, whereas the longer life of 
the 12-methyl metabolites probably helps to optimise the 
in vivo binding. In both systems, however, the binding of 
the 11-methyl ketone is considerably enhanced over the 12-methyl 
isomer•
4.3*3 The In Vivo Dose/Binding Relationship of the 11-Methyl 
ketone to DNA
An extension to previous'work, where mice were painted in-, the
14usual way with 1600 nmols of the 11-methyl ketone (I), was 
performed by painting batches of mice at doses of 5 0 ,100,200,
400 and 1000 nmoles per mouse. Sacrifice occurred after two 
days, when the adducts were obtained as previously outlined. 
Experiments by workers at the Imperial Cancer Research Fund, 
currently in progress, show that tumours are formed at doses 
as low as 50 nmoles per mouse, by topical application of the 
same compound.
The adducts showed a consistent pattern from both the LH20 
and the H.P.L.C., being very similar to those shown in Fig. 
4.3*2ii and Fig. 4.3«2v. A summary of the results is given 
in Table 4.10.
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Table 4.10 Dose/Binding relationship for the 11-Methyl 
ketone in vivo
Dose per Binding in Binding in Ratio Total Binding
mouse 'A1 peak fB' peak B:A (nmol/molDNA P)
(nmol) (nmol/molDNA P) (nmol/molDNA P)
50 6 29 4.8 35
100 5 50 1 0 .0 55
200 14 100 7.1 114
400 17 153 9.0 170
1000 25 433 17.3 458
1600 680
12-Methyl 60 96 156
(1000)
A linear relationship between total dose and binding ratio 
is evident and illustrated in Fig. 4.3«3i. There is no upper 
limit or saturation dosage. The line does not go through 
the origin, probably due to exchanged Iritium into the DNA.
The ratio of B:A*suggests that both fA f and fB f peaks do not 
increase in a linear manner, and graphs of them individually 
(Fig. 4.3.3ii and iii), show that while *B* is linear, the 
much rarer 'A1 adducts are related differently. Because of 
the small quantity of fA f formed, they do not significantly 
affect the overall figures for the total binding.
Investigation of the H.P.L.C. profiles enables the binding 
ratios for individual adducts to be determined. In particular 
that of the ultimate carcinogen resulting from reaction of
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the DNA with the 3idihydrodiol-1,2-oxide (V). Other adducts 
are only present in minimal quantities. The figures are given 
in Table 4.11, together with the corrected figures as only 
70% of the radioactivity was recovered. This enables a direct 
comparison to be made with the 12-methyl ketone binding ratio 
at a dose of 1000 nmoles per mouse.
Table 4.11 Dose/Binding relationship of dG — 3 1 4-Pihydrodiol- 
1 ,2-oxide adducts
Dose Binding Ratio Corrected Binding
(nmoles/mouse) (nmoles/moleDNA P) Ratio (nmoles/moleDNA P)
50 27 39
100 29 41
200 55 79
400 108 154
1000 193 278
12-Methyl (1000) 80 114
Again a linear relationship is found (Fig. 4.3«3iv ) with a 
saturation dose not reached, even at 1000 nmoles per mouse.
>r *ioo
Dose per mouse/ 
nmole
6 •
Binding R atio/
nmole per mole DNA P » _
300250200100 15050
Fig. 4.3-3iv Dose/Binding Curve for dG adducts of (I)
The quantity of the major deoxyguanosine adduct (presumed) of
the 12-methyl compound (III), -when applied at a dose of 1000
nmoles/mouse, falls within this range of study. It is denoted
on Fig. 4.3-3iv by /_ dG-12Me__/. Whilst the biological activity
13of the 11-methyl compound (I) is well determined, experiments 
using the 12-methyl compound (III) have failed to show any 
tumourogenicity at a dose of 1000 nmoles per mouse.
From both the total binding, and the binding of the specific 
adduct, it can be seen that biological activity is not simply 
determined by the quantity of deoxyguanonsine adduct, even 
when the stereochemical conformation of their diolepoxides are 
identical. A more subtle explanation of the relationship of 
DNA modification to carcinogenicity is therefore necessary.
4.3*4 The Rate of Excision of 12-Methyl ketone Adducts 
from DNA In Vivo
Groups of mice were painted with the 12-methyl ketone (III),
as previously described, at a dose of 1000 nmoles per mouse.
The animals were sacrificed at time points of 2,5 * 10, 14 and
20 days after application. As before, the DNA was extracted,
hydrolysed and the products chromatographed. Insufficient
binding was found to enable the second H.P.L.C. separation 
per-
to bej^formed. The data from the 20 day experiment was not 
used as contamination appeared to have occured.
The patterns of adducts from the LH-20 column were similar to 
others previously prepared, and the binding ratio of the A-, B 
and C peaks were determined. These are shown in Table 4.12 
together with the logarithm^ ^of these values
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Table 4.12 Dose/Binding relationship of 12-Methyl ketone (XXI) 
with time
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A plot cf the logjQ /. adduct concentration_J7 against time is shown for 
each of these srouDs ,in Fig. 4t.3»4ti-iv.
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A pattern is immediately observed showing a logarithmic 
relationship, from which the half life of the adducts in 
the DNA may be readily determined. The initial part of the 
curves are assumed, as maximum binding for the 11-methyl
1 4 18ketone is found 2-3 days after application. ”
The half life of 
in Table 4.13.
Table 4.13 Half
each of the groups of adducts is summarised 
lives of groups of adducts from (III) in viva
Group Half life (days)
total 3.6
A 3-7
B 3-3
C 3.8
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The half life is constant and relatively fas t (t-§-=3 • 3-3 .8
days), and compares with a rate of skin turnover of about 
14
six days. By comparison, the 11-methyl ketone (I) is lost
lk
from mouse skin with a half life of approximately 6. 5 days.
One minor adduct was lost with a half life of about two days.
The significance of this.is that the 11-methyl adducts are 
only lost from skin at the same rate as the skin is naturally 
lost. However the 12-methyl adducts are positively lost, 
presumably by DNA-repair enzymes present in mouse skin. These 
are able to excise 12-methyl ketone adducts, but not the 11- 
methyl adducts. This may yet prove to be one of the most 
significant differences between the two compounds, as they are 
displaying markedly different biological activity under the 
same conditions.. It would be interesting to study how other 
compounds in this series are lost from DNA in vivo, particularly 
the carcinogenic 7-rnethyl and 11,12-dimethyl (IV) compounds..
Abbott and Crew, in discussing the H-methyl ketone (t-g-=6-5
days), suggest that a species with a half life of the order
of 2-3 days, would be almost totally lost prior to cell 
14
division. Here, at least, a rationality for the non- 
tumourogenic activity of the 12-methyl* ketone (III) may be 
seen.
Alexandrov et al have recently reported the disappearance of 
a benzo-/ a_7-pyrenediolepoxide deoxyguanosine adduct from
19rat skin, where after three weeks none of the adduct remained.
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The skin of the rat is resistant to the induction of tumours 
with benzo-/ a__/-pyrene (XII). They compared this with 
mouse skin, where the compound is active, and found that at 
the end of a similar period of time, 6 .5% of the original 
adduct remained. They propose that the difference in 
biological activity is related to the excision of these 
adducts from the DNA.
In a similar manner it is proposed that the excision of the 12- 
methyl adducts is responsible, at leasit in part, for the 
lack of biological activity in this compound. It remains 
to be discovered why these adducts should be preferentially 
repaired over the similar 11-methyl adducts. It is possible 
that the 12-rriethyl group forces the molecule farther away 
from the backbone of the DNA, making the molecule more 
•accessible' for the repair enzymes. Alternatively, the 11- 
methyl group may induce an effect to negate the effect of 
these enzymes.
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Chapter 5
The Preparation of Some Tritiated Amino and Nitro Aromatic 
Compounds
5-1 Introduction
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5.2.1 Materials
5.2.2 Tritiation Method for the Nitroquinoline-oxides
5.2.3 Tritiation of Aromatic Amines and Hydrocarbons
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5.1 Introduction
Over the years many different compounds have been shown 
to be mutagenic and tumourogenic• These include polycyclic 
hydrocarbons, related compounds such as the 1 5,16-dihydro- 
cyclopenta-^ a_7 -phenanthren-17-ones, as well as heterocyclic 
analogues and nitro and amino substituted derivatives.
One of the latter is 4-nitroquinoline-1-oxide (I), which
1
was originally synthesised by Ochiai et al from quinoline-
oxide (II). Although its tumouricidal properties were first 
2noted in 1 9 5 5 1 it was not until two years later that its
3
carcinogenic activity was demonstrated. Many related
compounds have been subjected to such biological tests.
These have established that the 2-ethyl, 2-methyl and 7—chloro
derivatives of 4-nitroquinoline-1-oxide are active, but the
absence of either the nitro group or oxide, leads to inactivity 
4e.g. II— V.
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NO.
VIV
The 3-niethyl-4-nitroquinoline oxide (VI) was found to be 
weakly active, though less so than the parent compound (I). 
As such they make an interesting pair for studying their DNA 
binding and genetic activity.
NO.
Me
6
7
N+
0“
In order to conduct such studies, radiolabelled forms of the 
compounds are required. Tritium lends itself well to this 
purpose, owing to the ease of introducing the isotope, when 
compared with carbon-l4. The compounds may be directly
3
labelled by exchange, and the availability of H-nmr enables 
the distribution to be readily determined. Quinoline-1-oxide 
has been previously tritiated by base catalysed exchange.^
Polycyclic amino and nitro compounds have been implicated in 
chemical carcinogenesis in both man and laboratory animals.
21k
2-Naphthylamine (VII) has long been associated in the
7
cancer of the bladder. Following this discovery, investigations
suggested that the isomeric 1-naphthylamine (VIII) was also
involved in chemical carcinogenesis, though not to nearly the 
8 9same extent. However samples of 1-naphthylamine normally
contain small quantities of the carcinogenic 2-naphthylamine. 
When a higBly purified sample of the former was prepared and
10tested on animals, no evidence of tumour formation was found. 
Although the manufacture of the 2-amino isomer has now been 
banned, the 1-amino compound is still available.
NH.
7
6
5 4
NH.
Despite the apparent non-tumoarogenicity of 1-naphthylamine,
11 12the N-hydroxylated derivative (IX) is carcinogenic, 1
13and also mutagenic in the Ames test. Due to the instability
of the hydroxylamine, it is not available commercially, but may
1 kbe easily prepared from 1-nitronaphthalene (X)•
NHOH
IX
The necessity of radiolabelled samples of these amino compounds 
for metabolism and genetic studies, has resulted in experiments 
to tritiate catalytically both 1-naphthylamine and 1-nitro- 
naphthalene. The latter may then be reduced to the required 
N-hydroxy-1-naphthylamine (IX).
Nitroaromatics are known to possess both mutagenic and
tumourogenic . properties • In particular nitropyrenes have
15-19been found widely distributed in the environment and
20—21been shown to be extremely active in the Ames test.
In order to facilitate further biological investigation,
radiolabelled compounds are necessary. The exchange of tritium
using platinum oxide or similar catalysts, is ineffective,
as nitro-substituted compounds poison them. Alternative
methods are therefore dependent upon introducing the nitro
groups into tritiated nuclei. Classical nitration methods,
using nitric and sulphuric acids, are not practical, as much
of the tritium in the aromatic rings is exchanged under the
drastic experimental conditions. The oxidation of amino(aromatic
compounds to the nitro-derivitives, using trifluoroperoxyacetic
22acid is well documented. The conditions used are sufficiently 
mild to minimize isotopic loss. Alternatively, a recent 
paper has. outlined a method of nitrating polyaromatic hydro­
carbons using a solution of in dichloromethane, at room
23temperature•
Work has therefore been performed to prepare a series of 
tritiated nitro aromatic compounds, namely nitrobenzene (XI),
1-nitronaphthalene (X) and 1-nitropyrene (XII). Two methods 
have been attempted, the nitration of the tritiated parent 
hydrocarbons, benzene, naphthalene and pyrene, and the 
oxidation of tritiated aniline (XIII), 1-naphthylamine 
(VIII) and 1-aminopyrene (XIV).
N02
NH,
6
XIII
5
4
NH,
8
XIV
7
6 5
NO-
8
XII
7
6 5
The preparation of this series of compounds would enable an
understanding of the suitability of different methods of
production of nitro aromatic compounds to be gained. A
number of these compounds have previously undergone biological
tests, and the production'of radiolabelled samples of them
will be informative in itself. 1-Aminopyrene (XIV) is mutagenic
24without metabolic activation, and the potency of aniline
10(XIII) is still in some doubt. Nitrobenzene (XI) is widely
25
used, causing methemoglobinemia, although inactive in the 
26 1-Nitronaphthalene (X) is mutagenic in bacterial
21
Ames test.
tests in the absence of a S9 metabolising system.
5.2 Experimental
5.2.1 Materials
All the compounds were available commercially with the
exception of the nitroquinoline oxides and 1-aminopyrene
which were obtained from the Department of Genetics, University
of Swansea and the Cancer Research Unit, University of York,
_ 1
respectively. Tritiated water (50.Ciml ) was obtained from 
Amersham International p .1.c.. Hydrogen peroxide (85%) was 
kindly provided by La p orte Industries, Warrington, Lancashire.
5.2.2 Tritiation Method for the Nitroquinoline-oxides
The compound was taken (50-60mg) and dissolved in a minimum 
quantity of dioxan (A.R.), together with a crushed pellet 
of sodium hydroxide and tritiated water (5^1). The mixture 
was placed in a sealed tube at 85°C for 60 hours. The 
product .was extracted into chloroform, dried with Sodium 
sulphate (anhydrous), and the solvent removed. The radio­
labelled compound was dissolved in d^-dimethyl sulphoxide and
3 1subjected to both H and H-nmr analysis.
5.2.3 Tritiation of Aromatic Amines and Hydrocarbons
The compound was taken (lO-lOOmg) and added to the pre-reduced 
platinum oxide catalyst (80mg) which had been previously 
dried by a freeze drying procedure. Tritiated water ( 5M-1)
was added, and the mixture heated to the required temperature
for 72 hours. On completion of the exchange reaction, the
compound was dissolved in chloroform or diethyl ether, dried
with anhydrous sodium sulphate, freeze dried, dissolved in a
1 3deuterated solvent, and subjected to H and Ii-nmr analyses.
5.2.4 Oxidation of Aromatic Aminesto Nitro-aromatic Compounds 
using Trifluoroperoxyacetic Acid
The peroxy acid was prepared by the addition of trifluoro- 
acetic anhydride (4.54ml) to dichloromethane (10ml), followed 
by hydrogen peroxide (85%, 0.7ml), in a solution(at 0°C. 
Following five minutes of stirring, the reaction mixture was 
allowed to warm to room temperature. Ten percent of this 
solution was taken and the amine G ^ O m g , in dichloromethane, 
0.3ml) added over a time of fifteen minutes, whereupon the 
resultant mixture was refluxed for an hour.
The products were extracted into chloroform, dried, and
dissolved in a small quantity of dichloromethane, applied to
preparative t.l.c. plate (silica gel) and eluted with benzene
ethyl acetate (10:1). The desired nitro compounds were
removed and extracted into chloroform, freeze dried, and if
sufficiently radioactive (>4m.Ci) dissolved in deuterated
1 3solvent and subjected to H and Ii-nmr analysis.
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\ 5*2.5 Nitration of Aromatic Hydrocarbons using gas
The tritiated hydrocarbons were dissolved in dry dichloromethane 
(O.25mmol in 5- 10ml)• To this solution a previously prepared 
solution of ^ 2^4 ^as dichloromethane (25ml, containing
0 .023g of gas) was added, and left for the required time at 
room temperature. (One hour for pyrene, two days for naph­
thalene and benzene). The solution of the gas was made by 
bubbling the gas through the dried solvent ( 3A molecular 
sieve)• The products were extracted and purified in the 
same manner as described in 5*2.4.
5*2.6 Preparation of 1-N-Hydroxynaphthylamirie
1-Nitronaphthalene (250mg) was dissolved in a previously
prepared saturated solution of hydrogen sulphide and ammonia
in absolute ethanol (5ml). The reaction was left to proceed
o
overnight in the dark at 0 C. The product was collected by 
precipitation, following the addition of excess ice. The 
compound is very unstable at room temperature in the light.
As a solution in dimethyl sulphoxide the compound could be 
kept for longer periods at 0°C in the dark. Due to its 
instability the radioactive precursor, 1- nitronaphthalene 
was prepared, rather than tritiated 1-N-hydroxynaphthylamine 
(X).
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3 ° 3 Results and Discussion
3.3.1 Nitroquinoline-1-oxides
The results are summarised in Table 3*1 and Figures 3«3.1i-ii.
The assignments were made on the basis of a comparison of the
3 1 1 H-nmr ( H-decoupled) spectra with the H-nmr spectra (shown
together in Fig, 5-3-li and 3*3-lii). The fact that the 
1
H-nmr spectra of the tritiated products were no different to 
those of the starting compounds, indicated that no decomposition 
of the substrate had occured during the tritiation procedures. 
As was to be expected, labelling occurred at the position 
adjacent to the heterocyclic atom, but ndt exclusively. In 
compound (I) about 10% of the radioactivity is found in 
position 3, whilst in compound (III) mos t of the tritium is 
to be found in the methyl group.
Positions adjacent to a nitro group in aromatic compounds
are known to be susceptible to exchange reactions, as has
27been demonstrated in the 1,2- dinitronaphthalene series.
The methyl group in compound (III) will be quite acidic, 
partly due to the six-membered transition state illustrated 
in Fig. 5«3.1iii. For this reason, the group is heavily 
labelled.
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Table 5.1 Base catalysed tritiation results for the 
Nitroquinoline Oxides
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5»3»2 Aromatic Hydrocarbons
The experimental conditions used for the tritiations and the
3 1results obtained are given in Table 5»2. The H-nmr ( H
decoupled) of f_ G - b e n z e n e  consisted of a single line with
3
S=7«10ppm. The H-nmr spectra obtained for Naphthalene and 
pyrene were similar to those reported in Chapter 1. The 
compounds were used without dilution with inactive substrate, 
in order that the nitrated products could be of the maximum 
specific activity.
Table 5«2 Results of / G-^H /aromatic compounds
Compound Quantity Reaction Total Specific
of Temperature Radioactivity Activity ^
Compound (°C) (mCi) (mCimmol )
(mg)
Benzene 132 100
Naphthalene 15 100
Pyrene 63 170
108
60
168
60
512
539
225
5.3» 3 Aromatic Amines
The experimental conditions for the tritiation of these
compounds are summarised in Table 5«3« Details of the
3 1chemical shifts and assignments from the H-nmr ( H-decoupled) 
spectra are given in Table 5«^« The spectra are shown 
in Fig. 5»3»3i-iii» For all three compounds very uniform
labelling has been obtained. As in previous cases assignments
3 1of the H-nmr spectra have been made either via the H-nmr
spectra obtained of the tritiated compound or by reference
to standard reference s p e c t r a . ^ ^
Table 5*3 Experimental conditions for the tritiation of 
some aromatic amines
Compound Wt(mg) Temp Total Specific Spectra
(°C) Radioactivity Activity Number
(mCi) (m.Ci/mmol)
Aniline (XIII) 100 85 10 9-3 5-3.3i
1-Naphthy1amine 10 100 78 1120 5*3-3ii
(VIII)
1-Aminopyrene 15 190 80 1150 5-3-3iii
(XIV)
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3 1Table 5-4 Details of the H-nmr ( H-decoupled) spectra of 
various aromatic amines
Compound
NH,
6
Solvent (ppm) Assignment
XIII
NH.
7
VIII
6
5 4
NH.
i
XfV
Neat liquid 6 . 3 8  
6.66 
7.02
;CDC13 6.70
7-27 
7-31 
7-40 
7-44
7.74
7.79
dg-Dimethyl 7*59 
Sulphoxide 7•82
7.9^
7.96
8.04
8.08
8.40
2,6
4
3,5
2
3
4 
6
7
5
8 
2 
3
4+5+6+8 
+9 + 10
Relative 
Incorporation (0‘
39
19
42
l4
13
13
14 
14 
16 
16 
12 
12 
11 
10 
11
32 (3 H's with the 
same chemical 
12 shift)
5-3-4b Oxidation of Aromatic Amines
The use of trifluoroperoxyacetic acid to oxidise the amino 
compounds to the corresponding nitro compound, was limited to 
the production of nitrobenzene (XI) from aniline (XIII).
The results are summarised in Table 5*5 
Table 5-5 Oxidation of some aromatic amines
Starting
Compound
Initial Desired
Radioactivity Product 
(mCi)
10Aniline 
(XIII)
1-Naphthyl- ?8 
amine (VII) 
1-Amino- 80 
pyrene (XIV)
Radioactivity Spectrum 
Recovered Ref. No.
(mGi)
Nitrobenzene 8
(XI)
1-Nitronaphth- 10. 3 
alene (X) 
1-Nitropyrene lk
(XII)
5-3-4i
The radioactivity recovered amounts to the quantity of
tritium cochromatographing with the desired product on
the t.l.c. plate. With the polyaromatic compounds (VIII
and XIV), the products were many, and a number of them containing
3
radioactivity were very polar. No H-nmr spectra were 
obtainable from them.
The use of this method for the preparation of single ring
22aromatic compounds is well established. The presence of 
the polar products with the polyaromatic compound is probably 
as the result of epoxidation of the aromatic nuclei leading, 
by rearrangement, to the formation of phenols. Under similar 
conditions, it is known that such reactions o c c u r . ^ ’^
It would appear that the presence of a second ring helps to
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stabilize the epoxide formed. Thus the production of nitro- 
polyaromatic compounds is not practical by this method, 
although monocyclic compounds would appear to be readily 
prepared in almost quantitative yield, with minimum loss 
of tritium.
3
The H-nmr spectra of nitrobenzene taken as a neat liquid 
is shown (Fig. 5-3-^i) and the assignment is given in Table 5-6.
Table 5*6 Details of the ^H-ninr (^H-decoupled) of / G-^H 7 
Nitrobenzene
Compound s(ppm) assignment Relative incorporation {%)
NOj
U
7-14 3,5 5^-3
1Xl
7-31 k 1 5 - 6
7,75 2 ,6 3 0 . 1
4
0 66 210 7 5 311 9 8 4
Fig. 5.3.^!
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3.3*5 Nitration of Aromatic Hydrocarbons
The reported ready conversion of various polycyclic compounds,
23
in virtually quantitative yield, at room temperature, 
indicated a possible route to the preparation of 1-nitropyrene 
(XII) and 1-nitronaphthalene (X).
The preparation of nitrobenzene (XI) had not been reported. 
A summary of the results is given in Table 3*7
Table 3*7 Nitration of some aromatic hydrocarbons
Substrate Total Desired Radioactivity Spectrum
Radioactivity Product Recovered(mGi) Ref. No.
(mCi)
Benzene 108 Nitroben- 1
zene (XI)
Naphthalene 60 1-Nitronaph- 22 3-3»5i
thalene (X)
Pyrene (t8 1-Nitropy- l8 3-3-5ii
rene (XII)
As before, the radioactivity recovered corresponds to that
3
cochromatographing with the desired product. The H-nmr 
( H-decoupled) spectra (Figs. 5-3-5i and 3«3*5ii) obtained 
clearly illustrates the suitability of this method for the 
introduction of nitro groups into polyaromatic hydrocarbons, 
but not the monocyclic species, where insufficient product 
was formed.
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Fig. 5-3-51
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Fig. 5-3-5ii
Assignments are given in Table 5-8» and were made in
32 33conjunction with literature values. Deuterated pyridine
was used as the nmr solvent, as the nitrated products were 
very insoluble.
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3 1Table 5*8 Details of the H-nmr ( H-decoupled) spectra of 
various Nitroaromatic Compounds
Compound Svalue Assignment Relative Incorporation (%)
(ppm)
7.50 3 2 0 . 0
7.59 6 1 8 . 1
I4^rf 7 . 6 8 7 2 8 . 6
x
7-98 5 11.4
4
8 . 1 3 4 10.5
8 . 2 6 2 5-7
8 . 3 8 8 5-7
7.90 3 1 2 . 2
N O j
8 . 0 0  ^ 9+another 2 3 . 0
U 8 . 0 7  ! 9-9
8.14 7 ,8 , 6 1 1 . 8
XII 8 . 1 8 5 , 4
^ 4
8 . 2 0
J
► 1 9 . 8
8.37 2 12.3
8.74 10 9-0
The lack of reaction with benzene is probably because it 
is not activated to electrophilic attack, whereas the polycyclic 
compounds are. This may be seen when comparing the quite 
drastic conditions required for the nitration of benzene 
compared with the polyaromatic hydrocarbons, using the classical 
methods.
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The use of* these two different methods means that tritiated
nitroaromatic compounds may be readily prepared, with
3
reasonable specific activities, and by utilising H-nmr, 
the isotope distribution may be determined.
5-3*6 Preparation of 1-N-Hydroxynaphthylamine
The product was prepared as described previously, and stored
in deuterated dimethyl sulphoxide at 0°C in the dark.
1
H-nmr spectra were obtained at various time intervals, to 
determine the extent of decomposition. Under these conditions, 
the decomposition was slow . The initial H-nmr spectrum 
is shown in Fig. 5-3-6i
Fig. 5-3-6i
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